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Abstract  
 
Currently, the only treatment for end stage renal disease is dialysis or kidney transplantation. These 
methods contain obvious limitations such as the palliative nature of dialysis treatment and the lack of 
available organs for transplantation. As a result, there is a dire unmet need for alternative options. 
Regenerative therapies that focus on stimulating the regrowth of injured tissue can be a promising 
alternative. A critical step in the development of such therapeutic remedies is obtaining robust 
models that mimic the complex nature of the human kidney. The proximal tubules are a particular 
region of interest due to their important role in reabsorption and secretion of the glomerular filtrate 
and the blood, making them particularly susceptible to nephrotoxicity and renal pathologies. For this 
reason, the goal of this thesis was to engineer a 3D model of human proximal tubulogenesis that 
would allow for both developmental and regenerative studies. The ideal assay would mimic the 
human 3D structure and function of proximal tubules in a tunable, robust matrix that can be easily 
analyzed in throughput screenings for regenerative medicine and toxicity applications. 
 
In this thesis, we show the development, characterization, and application of an in vitro human renal 
tubulogenesis model using a modular and tunable biohybrid starPEG-heparin hydrogel platform. A 
range of hydrogel mechanics and compositions were systematically tested to determine the optimal 
conditions for renal tubulogenesis. The results revealed that only soft hydrogels based on heparin 
and matrix metalloproteinase (MMP) enzymatically cleavable crosslinkers led to the generation of 
polarized tubule structures. The generated tubules display polarization markers, extracellular matrix 
components, and organic anion transport functions which mimic the human renal proximal tubule. 
To the best of our knowledge, this is the first system where human renal tubulogenesis can be 
monitored ex vivo from single cells to physiologically sized tubule structures in a 3D tunable matrix. 
Moreover, it was found that heparin played a role in the polarization of proximal tubule cells in the 
hydrogel culture.  
 
The established starPEG-MMP-heparin based hydrogel model was then tested for its application as a 
renal tubulogenesis model by the addition of pro and anti-tubulogenic factors. It was found that the 
addition of growth factors and MMP inhibitors could promote and inhibit tubulogenesis, 
respectively. This model can be used to modulate tubulogenesis by adjusting the mechanical 
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properties of the hydrogel, growth factor signaling, and the presence of insoluble cues (such as 
adhesion peptides), potentially providing new insights for regenerative therapy.  
 
To examine if the established hydrogel-based renal tubulogenesis model could be applied as a drug 
toxicity platform, the nephrotoxic, chemotherapeutic drug, cisplatin was incubated with the renal 
tubule model. The tubular structures showed a dose-dependent drug response resembling the human 
clinical renal pathology. The injured tubular structures also expressed the early in vivo proximal tubule 
injury biomarker, kidney injury molecule-1 (KIM-1).  
 
In conclusion, a hydrogel-based renal tubulogenesis model was successfully developed, characterized, 
and applied as a nephrotoxicity assay. Our findings suggest that the established hydrogel-based 
model can additionally be used for personalized medicine, where a patient’s predisposition to drug-
induced renal injury or specific renal regenerative medicine treatments could be examined. This 
platform provides a novel approach to study human nephrotoxicity and renal regenerative medicine 
ex vivo, limiting the need for animal models, and potentially paving the way for more reliable 
preclinical trials. 
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Chapter 1 
Introduction 
1.1 Motivation   
It is estimated that one in ten American adults currently suffer from some degree of chronic kidney 
disease (CKD)1. CKD is a progressive loss of kidney function that in early phases can often go 
unnoticed. Without treatment, CKD can progress to end stage renal disease, a condition where the 
kidneys retain less that 10-15 percent of their normal function. The only treatment options for 
ESRD are dialysis, a palliative treatment, or kidney transplantation.  
 
More people are waiting for kidney transplants than any other organ. In the United States alone, 
more than 99,000 people are currently on the waiting list for a kidney transplant2. Only a small 
amount, less than 1/3, will receive a kidney. In addition to recovering from the invasive surgery, they 
will also have the burden of taking immunosuppressant medication for the rest of their lives to 
decrease the chance of kidney rejection. This medication will make them more susceptible to 
infections, high blood pressure, weight gain, and can even increase the risk of some types of cancer3. 
Thus, the current treatment options for ESRD are immensely unsatisfactory. 
 
Regenerative medicine is a promising alternative to the current therapeutic treatment options of 
CKD and ESRD. Regenerative medicine therapies use the body’s own mechanisms to recreate the 
injured sites4. In this way, tissues and organs can be rebuilt using normal physiological processes and 
potentially provide a cure, rather than a palliative treatment. Despite ongoing research into the 
regenerative capabilities of the kidney, much is still unknown about regenerating the nephrons, the 
functional units of the kidney5–7. The proximal tubules are the region most targeted by renal 
pathologies and drug-induced injury and consequently much interest is focused on the renewal of 
these structures. In vivo studies of the proximal tubule are limited due to the complex anatomy of the 
kidney, which makes visualization of specific functions complicated.  
 
To establish novel regenerative renal therapies, a reliable model of the human kidney or human 
proximal tubule is needed. To date, an in vitro renal tubule model that fully recapitulates the complex 
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3D physiology of the kidney has not yet been created. As a result, animal models and 2D cell culture 
models are often used in preclinical trials. However, results from animal models contain interspecies 
differences. For example, the kidneys are a major target of drug-induced toxicity and a limited 
number of animal experiments accurately predict the human response to drugs8,9. As a consequence, 
adverse reactions are often not found until human clinical trials. Alternatively, cells grown on 
conventional 2D tissue culture substrates lack the 3D cell-cell and cell-matrix interactions that are 
crucial in maintaining cell phenotype and function, and therefore, are not accurate representations10. 
For these reasons, 3D models have recently been gaining interest as promising approaches to 
generate more realistic renal models.  
 
1.1 Objectives 
The ideal renal model should recapitulate the human 3D structure and function of the kidney, 
especially the proximal tubules which play a crucial role in maintaining homeostasis and toxin 
excretion. The model should also be robust and easily analyzed so that it can be used in throughput 
screenings for applications in regenerative medicine and toxicity. The aim of this study was to 
establish a 3D renal proximal tubulogenesis model using starPEG-heparin hydrogels.  
 
A renal tubule model should replicate in vivo renal tubulogenesis so that this process can be studied 
for renal regenerative medicine. Thus, the matrix should be tunable, allowing for the adjustment of 
mechanical and biomolecular factors to dissect their effects on tubulogenesis. Another important 
application for a renal tubulogenesis model is as a nephrotoxicity assay because the proximal tubule 
is a major target of drug toxicity. The generated tubules could be incubated with potential drug 
candidates to assess their toxicity to the kidney. Additionally, the model could be used as a renal 
disease model or as a source of cells for therapy.  
 
To accomplish the goal of creating an in vitro 3D renal tubulogenesis model, the project was broken 
down into six main objectives: 
 
1.) Evaluate the conditions to induce tubule formation in biohybrid starPEG-heparin hydrogels.  
 
2.) Characterize the renal structures produced in different hydrogel variants to determine the 
condition that best replicates the physiological human tubule. 
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3.) Examine the impact of soluble cues on the renal tubulogenesis model. 
 
4.) Evaluate functionality of the tubulogenesis model by examining the function of organic 
transporters, which are important for the removal of potentially toxic drugs, metabolic 
wastes, and drug metabolites. 
 
5.) Investigate the application of the model for ex vivo renal tubulogenesis using primary human 
proximal tubule epithelial cells. 
 
6.) Probe the potential of the model as a human nephrotoxicity assay by analyzing the response 
to the nephrotoxin, cisplatin. 
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Chapter 2 
Fundamentals 
This chapter will provide the framework of information needed to understand the scope of this 
thesis. First, the kidney physiology is briefly introduced. Then the anatomy of the nephrons, the 
functional units of the kidney, is presented. Next, the function and structure of the proximal tubule, 
an invaluable part of the nephron, are discussed, followed by what is currently known about renal 
tubulogenesis. The next section describes the kidneys susceptibility to drug toxicity. Finally, the 
advantages and disadvantages of the current state of in in vitro biomaterial-based renal models are 
discussed and starPEG-heparin hydrogels are proposed as a promising alternative.  
 
2.1 Kidney physiology 
The kidney is a complex organ that consists of more than 20 different specialized cell types and plays 
a critical role in maintaining body fluid homeostasis. The kidney receives about 25% of cardiac 
output, roughly 180 liters of blood daily which it filters for toxins, metabolic wastes, and ions. Blood 
enters the kidney through the renal artery, where it is heavily filtered and then removed through the 
renal vein. The kidney also regulates the body’s fluid levels of electrolytes, and produces hormones to 
maintain blood pressure and healthy bones11. Specifically, the kidney yields the hormones renin, 
erythropoietin, vitamin D, and prostaglandins12.  
 
The complete renal system consists of two kidneys located on each side of the spine, beside the 
posterior wall of the abdomen. Each kidney is enclosed by a fibrous capsule made of a dense 
network of primarily collagen and elastin fibers; this serves as protection to the kidney13. Under the 
kidney capsule, the renal parenchyma can be broken down laterally into conical lobes termed renal 
pyramids that consist of an outer region called the cortex, an outer and inner medulla, and the 
papilla. The papilla is the location where urine drains into the minor and major calyces and eventually 
to the ureter, where it is then secreted into the bladder14. 
 
During development, the human kidney is formed from the intermediate mesoderm (IM), located 
between the paraxial mesoderm and the lateral plate mesoderm in the developing embryo. From this 
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tissue, the ureteric bud (UB) and metanephric mesenchyme (MM) are formed. A complex interplay 
between these two structures induces UB to undergo branching morphogenesis and the MM to 
undergo mesenchymal-to-epithelial transition, which produces a polarized epithelial structure. This 
polarized epithelial structure is termed the renal vesicle and it develops into a comma-shape, and 
then a S-shaped body with cells that eventually differentiate into the specialized sections of the 
nephron15. 
 
The following chapter gives an overview of the nephron and its importance in the kidney, with an 
emphasis on the proximal tubule and the previous models to recreate these structures in vitro. 
 
2.1.1 Nephron anatomy 
The average adult human kidney contains around 1 million nephrons, which are responsible for the 
vital functions of the kidney. In humans, nephrogenesis is fully completed intrauterine, meaning that 
new nephrons do not form during an individual’s life16. The nephron consists of two parts, the renal 
corpuscle and the renal tubule. Nephrons are formed from the renal vesicle that develops into an S-
shaped body. The lower (proximal) limb of the S-shaped body develops into the renal corpuscle and 
the distal end forms the renal tubules17 (Fig. 2.1.1).  
 
The renal corpuscle contains the glomerulus, Bowman’s space, and Bowman’s capsule and is formed 
when the initial end of the nephron encapsulates a mass of capillaries, known as the glomerulus. The 
glomerulus is essentially a tuft of capillaries that protrudes into the Bowman’s space (urinary space) 
and is surrounded by the Bowman’s capsule. The renal corpuscle contains three different types of 
cells: mesangial cells, endothelial cells, and the specialized epithelial cells, podocytes. The specialized 
capillaries are held together by the mesangial cells and this section is covered by the glomerular 
basement membrane (GBM) followed by a layer of podocytes on the outer surface18. The glomerulus 
filters the blood brought in by the capillaries for macromolecular molecules, allowing only molecules 
with a molecular weight less than 70 kDa to pass through the filter19. The charge, shape, and 
flexibility of the molecule also influence its ability to be cleared from the glomerulus. The resulting 
filtrate is then collected in the Bowman’s space, which opens into the tubular lumen, and later into 
the collecting ducts (Fig. 2.1.1.). Non-filtered blood components such as blood cells will leave the 
glomerulus through the efferent arteriole.  
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Figure 2.1.1. Kidney and nephron anatomy. Approximately 1 million nephrons construct the average human kidney. 
The nephron can be divided into the following sections: glomerulus, proximal tubule, loop of Henle, distal tubule, and 
the collecting duct. The proximal tubules play an important part in reabsorption and secretion of important factors in the 
blood and filtrate and will be the focus of the thesis. Adapted from Sanchez-Romero et al20. Copyright permission 
granted from Elsevier Publishing Group.  
 
At the urinary pole, the Bowman’s capsule turns into the epithelium of the tubule region of the 
nephron21. The tubule is characterized by different segments pertaining to their specialized secretion 
and absorption functions (Fig. 2.1.2). The first section is the proximal tubule which has a simple 
cuboidal epithelium and is responsible for reabsorbing the majority of the filtrate (Fig. 2.1.2). For this 
reason, the proximal tubule contains a dense brush border made up of microvilli to enlarge the 
absorption area. The majority of the proximal tubule resides in the renal cortex of the kidney. The 
proximal tubule then lowers into the renal medulla where the cells obtain a flatter morphology with 
less microvilli, and become the Loop of Henle14.  
 
The Loop of Henle can be divided into three parts, the descending thin limb, the ascending thin 
limb, and the thick ascending limb (Fig. 2.1.2). The thin limbs are composed of simple squamous 
epithelia that are 15-30 μm in diameter and have a cell size of 1-5 μm and the thick ascending limb 
consists of cuboidal epithelia22,23. The different segments have distinct functions based on the overall 
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role of the loop to reabsorb salt (NaCl) and water. The descending limb is freely permeable to water, 
thereby being the location of water reabsorption, whereas the ascending limbs are less permeable to 
water and the site of reabsorption of sodium chloride (NaCl)24 (Fig. 2.1.2). The thick ascending loop 
returns to the renal cortex and transforms into the distal convoluted tubule which regulates sodium, 
potassium, and divalent cation homeostasis25 (Fig. 2.1.2). The distal tubules from several nephrons 
converge onto a single collecting duct and the accumulation of collecting ducts form the renal 
papilla. From the collecting duct, the filtrate travels into the ureter and then to the bladder where it is 
later excreted from the body as urine. 
 
 
Figure 2.1.2. Summary of the functions of each region of the nephron. The glomerular filtrate travels through the 
nephron and is eventually excreted from the body as urine. Adapted from DesRochers et al.26  
 
2.1.2 Proximal tubule ultrastructure and function 
Proximal tubules play a crucial role in the function of the nephron. They are responsible for 
reabsorbing approximately 65% of the filtrate including amino acids, low molecular weight proteins, 
salt, potassium, and water27. They also regulate the acid-base balance in the body by reabsorbing 80% 
of the filtered bicarbonates and reabsorb glucose to maintain glucose metabolism27,28. The differences 
between mammalian proximal tubule cells among species is mostly based on size and amount of cell 
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organelles29. As all of the experiments in this thesis pertain to human cells, the following section will 
focus on the human proximal tubule.  
 
The human proximal tubule is about 10-14 mm long and 30-60 μm wide and can be divided into 
different segments, the convoluted tubule(called S1 and S2) and the straight tubule (referred to as the 
S3 segment)23,30. Each segment has a distinct morphology to fulfill their physiological roles. Proximal 
tubules consist of cuboidal epithelial cells that have an apical basal polarity21. The apical side of the 
cells faces the lumen of the tubule and contains a dense border of microvilli termed the brush border 
(Fig. 2.1.3). The brush border creates a larger surface area to allow for more cell adsorption, a key 
role of the proximal tubules.  
 
Each proximal tubule cell has a single primary cilium on the apical surface that senses changes in 
luminal flow rate and circumferential stretch21,31. Inside the cell, the Golgi apparatus is located near 
the apical membrane and the round nuclei are usually situated near the cell base or centrally23,30 (Fig. 
2.1.3). The basal membrane is partitioned into interdigitating basolateral folds which enclose 
mitochondria (Fig. 2.1.3A). The cells are attached to neighboring cells through junctional complexes 
near the apical surface, specifically the tight junction (zonula occludens, ZO-1) and the intermediate 
junction (zonula adherens) (Fig. 2.1.3A). Tight junctions are important for preserving the barrier 
between the lumen of the tubule and the interstitium. However, some disruptions in tight junctions 
allow certain molecules to be reabsorbed through a paracellular path30.   
 
The S1 segment of the proximal tubule is the region directly in contact with the renal corpuscle. 
Proximal tubule cells in this region have a greater density of microvilli, deeper basolateral membrane 
infoldings, and a higher amount of mitochondria to provide energy for solute transport. The S1 
segment also shows extensive endocytosis near the apical membrane consisting of endosomes, 
vesicles, and invaginations (Fig. 2.1.3). In addition, many lysosomes are available to process and 
degrade the incoming material. The later segments (S2 and S3) have microvilli that are shorter and 
sparser (e.g. less surface area) and less mitochondria, indicating that less reabsorption occurs in these 
segments30. The later segments also have tighter junctional complexes, making them less permeable 
to solutes and fluid32.  
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Figure 2.1.3. Morphology of the proximal tubule epithelial cell. A) Schematic of a cuboidal proximal tubule cell. 
Adapted from Krstic23. Copyright permission granted by Springer Publishing Group. B) TEM micrograph of a human 
proximal tubule cell. Adapted from Møller eta al.33. Mv presents microvilli which make up the brush border (BB) of the 
cell. L represents lysosomes, CV and V are condensing vesicles, G is the Golgi apparatus, M are the mitochondria, N is 
the nucleus, BL is the basal lamina with BLa being the basal labyrinth that is formed from the basal invaginations (Inv). S 
are saccules, P are cell processes, J are the junctional complexes that connect neighboring cells, and Pr are sheet-like 
processes that interlock with processes from neighboring cells. C refers to a peritubular capillary (C).  
 
The base of the proximal tubule cells is attached to the basement lamina which is a thin sheet of 
extracellular matrix that coats the outer surface of the proximal tubule and part of the tubular 
basement membrane. The main components of the renal proximal tubule basement membrane are 
laminin-1, laminin-10, collagen IV, entactin/nidogen, perlecan, and bamacan. The composition of 
the basement membrane is important for the function of the proximal tubule since they are 
continuously absorbing and secreting molecules from the surrounding peritubular capillaries. 
 
The proximal tubule is the first region of the tubule that the glomerular filtrate enters after 
ultrafiltration by the glomerulus. Therefore, it is the location where most of the reabsorption of the 
glomerular filtrate takes place. As the glomerulus filters high molecular weight proteins, the proximal 
tubule filters the remaining proteins and molecules out of the filtrate through endocytosis, namely, 
peptide hormones and albumin are reabsorbed. They also reabsorb amino acids, low molecular 
weight proteins, salt, potassium, and water. The majority of solute and water reabsorption in the 
proximal tubule takes place in an isotonic manner causing minimal changes in luminal osmolarity of 
the filtrate.   
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Proximal tubule cells have Na+/K+-ATPases along their basolateral membrane which are active 
transporters that pump sodium out of the cells while driving potassium into the cells. This creates a 
negative membrane potential inside the cell and a Na+ gradient which stimulates the reabsorption of 
Na+ and Cl- from apical transporters. Cl- is released from the cell basolaterally through Cl- carrying 
exchangers and cotransporters. This process is mostly responsible for the large amount, about 60-
70%, of NaCl and water that is reabsorbed by the proximal tubule34. The Na+ gradient is crucial for 
the cell because of the various Na+ dependent countertransporters and cotransporters that are 
responsible for the uptake of HCO3
- and other solutes.  
 
Another important function of the proximal tubule is the adsorption of metabolites from the 
glomerular filtrate. The human kidney filters about 180 g of glucose and 50 g of amino acids per day 
and 99.8% of these metabolites are reabsorbed from the filtrate by the proximal tubules34. Glucose 
transport from the lumen through the proximal tubule cells is mediated by the two Na+-dependent 
transporters SGLT2 and SGLT1. SGLT2 is expressed on the apical membrane of the S1 and S2 
segments of the tubule and extracts the majority of the filtered glucose and functions as a 
cotransporter of glucose and one Na+ ion 21. SGLT1 is located on the apical membrane of the S3 
segment and cotransports two Na+ ions per glucose. The two transporters work effectively to 
reabsorb almost all of the filtered glucose from the glomerular filtrate. Glucose is then passively 
transported from the proximal tubule cells into the interstitial space through the Na+ -independent 
glucose transporters, GLUT2 and GLUT1. 
 
The process of transporting amino acids is more complex with the transporters depending on the 
structure and ionic properties of the molecule. The majority of amino acids that are absorbed 
through the apical membrane are neutral amino acids transported by the Na+-dependent 
cotransporter, B°AT1, which is located in the early portion of the proximal tubule35. Acidic amino 
acids are recovered through the Na+ and H+-dependent cotransporter, while an antiporter governs 
the uptake of basic amino acids and cysteine, and exchanges them for a neutral amino acid34,36. This 
complex process leads to a majority of amino acids being reabsorbed and leaving only a small 
amount in the final urine37.  
 
In addition to the absorption of molecules, the proximal tubules also play an important role in the 
excretion of organic anions and cations. The transporters involved are part of the SLC22 family of 
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transporters and are divided into groups based on substrates and mechanism, namely the organic 
cation transporters (OCTs), the organic anion transporters (OATs), and the zwitterion-cation 
transporters (OCTNs)21. They transport organic and xenobiotic substrates such as drugs, toxins, 
hormones, pollutants, and cellular metabolites from the blood to the urine. There are three OCT 
transporters (OCT1, OCT2, and OCT3) and are located on the basolateral membrane (Fig. 2.1.4). 
They are potential-sensitive, reversible, and Na+-independent, and transport organic cations and 
weak bases21. In contrast, there are six OAT transporters which play a crucial role in the excretion 
and detoxification of drugs, toxins, hormones, and neurotransmitter metabolites. OAT1 is expressed 
on the basolateral membrane of the proximal tubule and functions as an organic anion-dicarboxylate 
exchanger by releasing α-ketoglutarate or glutarate to provide the force for organic anion uptake into 
the cell. OAT2 is expressed in the liver and to a smaller degree in the kidney, where it is located on 
the basolateral membrane of the proximal tubule. OAT2 is Na+-independent and an organic anion-
dimethyldicarboxylate exchanger. OAT3 is an organic anion-dicarboyxlate exchanger that is driven 
by the translocation of glutarate 21. It is also predominately located on the basolateral membrane of 
proximal tubule cells whereas OAT4 is located on the apical membrane. OAT4 plays a role in 
reabsorption of organic anions from the filtrate.  
 
Additionally, another category of transporters localized to the proximal tubule is the ATP-binding 
cassette (ABC) transporter family. These include multidrug resistance proteins 2 and 4 (MRP2/4), 
breast cancer resistance protein (BCRP), and (P)-glycoprotein (MDR1/P-gp)20 (Fig. 2.1.4). The 
excretion of endogenous and xenobiotic anionic substances from the cell to the filtrate is performed 
by MRP2 and MRP4, which are localized on the apical membrane of the proximal tubule38. These 
transporters are ATP-dependent pumps that modulate the movement of a broad range of substrates 
into the filtrate to be excreted from the urine. 
 
Ex vivo studies have verified the transport of organic anions in the proximal tubule through the 
utilization of fluorescent dyes. For example, Masereeuw et al. isolated rat kidneys for ex vivo perfusion 
tests for the investigation of individual organic anion transporters. They supplemented perfusion 
media with the organic anion fluorescent dye, Lucifer yellow (LY). Results showed that LY was 
successfully cleared from the rat kidneys and this clearance could be reduced by the addition of the 
organic anion transporter inhibitor, probenecid39. The LY clearance was also reduced by the addition 
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of the organic anion, α-ketoglutarate to the perfusion media, proving that LY is partially transported 
through the α-ketoglutarate dependent OAT transporters.  
 
 
Figure 2.1.4. Schematic of the organic transporters in proximal tubule cells. OATs are organic anion transporters 
and OCTs are organic cation transporters. Transporters of the SLC family are marked in blue and ABC transporters are 
marked in red. The movement of ions is shown with grey arrows. Adapted from Sánchez-Romero et al20. Copyright 
permission granted by Elsevier Publishing Group. 
 
To explore the organic transport process further, another experiment was performed using isolated 
killifish renal proximal tubules, which tubule ends reseal following isolation. LY was again added to 
the media and the tubule was imaged with confocal microscopy. Micrographs showed that that 
fluorescence intensity was the highest in the lumen of the tubule and the fluorescence intensity of the 
cells was higher than that of the medium, indicating that LY is transported through the cells and into 
the lumens of the tubule. By supplementing various inhibitors into the media and monitoring LY 
accumulation, Masereeuw et al. were able to show that proximal tubule cells uptake LY on the Na+-
dependent basolateral carrier for small organic anions, whereas about half of LY is transported to the 
lumen through the Na+-independent transporters, potentially being the multidrug resistance-
associated protein (MRP)39. This study demonstrates the complexity of organic transport through the 
proximal tubule and how xenobiotics can enter proximal tubule cells through one organic anion 
transport system and be secreted into the lumen on multiple carrier systems.  
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The proximal tubule has a complex role in the reabsorption of important nutrients and ions from the 
filtrate to maintain homeostasis and the transportation of potentially toxic compounds from the 
blood to the urine. In addition, the proximal tubule also secretes H+ and K+ ions to regulate the pH 
of the filtrate, has endocrine and immune characteristics, and performs hydroxylation of vitamin D. 
Altogether, the proximal tubule is one of the most important parts of the nephron and thus, 
functioning proximal tubules are essential to maintain healthy kidney function.  
 
2.1.3 Renal tubulogenesis 
In the previous section the many functions of the proximal tubule were described, highlighting their 
importance in the kidney. Due to the fact that they are the first tubule segment to be in contact with 
the filtrate, as well as being responsible for mass reabsorption of solutes and transportation of toxins, 
proximal tubules are the target of many renal pathologies and drug-induced toxicity. For these 
reasons, much interest is focused on the regeneration of proximal tubules, specifically on the 
generation of proximal tubules in vitro, where tubulogenesis can be thoroughly studied for 
regenerative therapy. 
 
Renal tubulogenesis is a complex process involving the interplay of cell-cell interactions, extracellular 
matrix, and growth factors. The first known renal tubulogenesis model was established in 1991 by 
Montesano et al. with Madin-Darby canine kidney (MDCK) epithelial cells cocultured in collagen I 
gels with fibroblast or fibroblast conditioned medium40. The study found that MDCK cells cultured 
in collagen I formed cysts, but when cultured in collagen I gel with fibroblast conditioned medium 
they underwent tubulogenesis. They also found that the pro-tubulogenic effect could not be repeated 
by the addition of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), acidic 
fibroblast growth factor (aFGF), transforming growth factor beta 1 (TGFβ1), insulin-like growth 
factor I(IGF-1), insulin-like growth factor II (IGF-11), platelet derived growth factor (PDGF), or 
keratinocyte growth factor (KGF).  
 
With further probing, the same lab discovered that hepatocyte growth factor (HGF) was indeed the 
fibroblast-derived molecule that induced tubulogenesis in MDCK cells41. Hepatocyte growth factor, 
also known as scatter factor, was first identified as a regulator of liver regeneration. Since then, HGF 
was found to have stimulatory effects on a range of cell types, including the proximal tubule cells42. 
HGF has also been discovered in the peritubular interstitium of the rat kidney, and results from in 
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situ hybridization after induced injury in a rat kidney, suggest HGF was produced by endothelial 
cells43. Montesano et al. proved the importance of HGF in MDCK tubulogenesis by incubating 
human fibroblast conditioned medium with HGF antibodies. This led to a dose-dependent inhibition 
of tubulogenesis with complete suppression at higher concentrations. It is also important to note that 
the medium used contained 5% fetal calf serum (FCS). FCS is a common supplement to cell culture 
media that contains a complex mixture of proteins, growth factors, hormones, nutrients, and trace 
elements44. Nevertheless, this was a breakthrough in renal tubulogenesis at the time and many 
subsequent studies after have used this established model to study tubulogenesis.  
 
Tubulogenesis mechanisms of epithelial cells such as mammary gland cells undergo morphogenesis 
through one of the following methods: rubber-sheet deformation or dissociation-reassociation (Fig. 
2.1.5) 45,46. Rubber-sheet deformation is when cells remain intact in their correct apical basolateral 
orientation and remodel through invagination or evagination. In the second process, dissociation-
reassociation, some cells in the epithelium lose cell-cell contact, migrate, and the reassociate into a 
tubule. This second process is seen in nephrogenesis during kidney development46.  
 
Pollack et al. used the HGF-induced MDCK tubulogenesis model to investigate the mechanism 
behind renal tubule formation. Using basolateral and apical markers, they were able to follow the 
polarity of the epithelial cells throughout tubule formation. They found that cell-cell contacts are 
retained throughout all stages of tubulogenesis, yet polarity is transiently lost and then restored 
during the formation of tubule lumens in the regions of developing tubules47. This process is shown 
in Figure 2.1.6 and can be divided into four morphologically distinct stages after the formation of 
cysts. First, individual cells from the cyst put out membrane protrusions into the extracellular matrix, 
this phase is called extensions. The extension is followed by chains of cells that are connected to the 
cyst. A few days later, cords forms that are two to three cells thick and have discontinuous lumens. 
During the fourth and final stage, the discontinuous lumens coalesce, become continuous with the 
lumen of the cyst, and form tubules47. 
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Figure 2.1.5. Proposed mechanism of epithelial tubulogenesis. Rubber-sheet deformation occurs through the 
evagination or invagination of an intact epithelium. Dissociation-reassociation occurs through cells losing cell-cell 
contact, migrating, and then reassociating into a tubule structure. Graphic adapted from O’Brien46. 
 
Interestingly, the proposed method does not fall into the previously established mechanisms of 
rubber-sheet deformation or dissociation-reassociation, but instead has unique characteristics 
resembling parts from each process. For example, in the rubber-sheet deformation process, the cells 
keep their polarity, however MDCK cells were seen to transiently lose their polarity through the 
morphogenesis process (Fig. 2.1.6 B), yet they also did not detach from the cysts as the dissociation-
reassociation process predicts. Therefore, MDCK cells undergo a novel process of tubulogenesis. It 
is also important to note that MDCK cells used in this study were derived from a heterogeneous 
parent line of MDCK cells, which are believed to be derived from the distal tubule or collecting duct 
of the nephron. Therefore, it is possible that MDCK cells have different mechanisms of 
tubulogenesis than proximal tubule cells, the subject of this thesis.  
 
There also may be differences between tubulogenic stimulators. For example, Barros et al. found that 
the murine inner medullary collecting duct cell line (mIMCD-3) can form tubule structures when 
cultured in collagen I gels in the presence of serum whereas MDCK cells cultured in the same 
conditions were unable to form tubule structures48. Nevertheless, understanding tubulogenesis 
mechanisms in one renal epithelial cell type can provide important insights into the modulators of 
tubulogenesis in another type. The following section will cover the extracellular matrix (ECM), 
growth factors, and proteases that have been found to play a role in tubulogenesis of renal epithelial 
cells, with emphasis on the renal tubule. 
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Figure 2.1.6. Mechanism of tubulogenesis in HGF-treated MDCK cells proposed by Pollack et al47. MDCK cells 
stained at different stages of tubulogenesis for nuclei (red) and actin (green). In schematic, blue lines represent cell-cell 
contacts, red, represents free membrane (apical) surfaces, and green represents cell-matrix contacts. Four stages of 
tubulogenesis: A) extensions, B) chains, C) cords, and D) tubules. Graphic adapted from O’Brien 46. 
 
The extracellular matrix is an important factor in regulating tubulogenesis, as it provides mechanical 
stability, as well as adhesion sights for cells. Extracellular matrices also contain proteoglycans 
attached to glycosaminoglycan (GAG) chains that have the ability to bind to many growth factors 
through electrostatical charges. Therefore, extracellular matrix composition plays a vital role in 
contributing to epithelial morphogenesis. Santos et al. used the same conditions as the previously 
established HGF induced MDCK tubulogenesis model, except embedded in Matrigel instead of 
collagen I. Interestingly, MDCK cells did not form branching structures when cultured in Matrigel49. 
Matrigel is a commercially available reconstituted basement membrane derived from mouse sarcoma 
tumors. It contains ECM components that are native to the renal basement membrane would be 
expected to mimic a more in vivo like environment compared to collagen I which is not a component 
of the renal tubule basement membrane (discussed in detail in Section 2.1.2)50. Even when the HGF 
concentration was increased fivefold compared to the 20 ng/ml HGF used for collagen gels, MDCK 
cells still did not form tubule structures, signifying the importance of ECM in tubulogenesis.  
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To further probe the effect of specific ECM components and determine stimulatory and inhibitory 
factors, Santos et al. mixed single extracellular components with collagen I and embedded MDCK 
cells in the resulting matrix. Specifically, the ECM components tested were laminin, entactin, 
collagen type IV, fibronectin, vitronectin, and heparan sulfate. Interestingly, the addition of laminin, 
entactin, and fibronectin to collagen I gels led to an increase in the amount of MDCK colonies with 
extensions compared to collagen I gels49. In contrast, MDCK cells in collagen I mixed with heparan 
sulfate or collagen IV inhibited the number of colonies with extensions and resulted in round cysts. 
Vitronectin also inhibited the amount of processes and tubules formed in this condition showed a 
minimal amount of branching. Taken together, these results demonstrate that ECM composition can 
modulate tubulogenesis and drive the branching of renal structures.  
 
The ability of the cells to degrade ECM is another important aspect of tubulogenesis, as cells need to 
be able to migrate and remodel the matrix to form tubule structures. Therefore, it is reasonable to 
assume that matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) 
also play an important role in tubulogenesis. HGF has been seen to increase the release of certain 
MMPs from MDCK cells51 and proximal tubular epithelial cells52. Kadono et al. found that 
membrane type-1 MMP (MT1-MMP) mRNA was upregulated in HGF-treated MDCK cells grown 
in collagen gels53. When the cells were transfected with MT1-MMP antisense RNA to repress 
translation of MT1-MMP, tubule formation was inhibited. Another way they could reduce tubule 
formation was with the addition of the broad spectrum MMP inhibitor, BB-94, or the intrinsic tissue 
inhibitor of metalloproteinase-2 (TIMP-2). However, TIMP-1 did not have the same effect.  
 
Interestingly, a decade later, Hellman et al. found that TIMP-1 is highly upregulated in MDCK cells 
treated with HGF in a collagen matrix54. It is possible that TIMP-1 is a promoter rather than an 
inhibitor of tubulogenesis, a potential reason for this is that TIMP-1 induces the upregulation of 
MT1-MMP, which we previously have stated is involved in tubulogenesis55. Another reason is that 
TIMP-1 has anti-apoptotic function of TIMP-1 reported in other studies which could help regulate 
cell apoptosis and create the lumens necessary for tubulogenesis56. The same study also found that 
MMP-13 mRNA was also highly upregulated with HGF treatment. Using MMP13 knockdown cells, 
they revealed that MMP13 is necessary for the redifferentiation stage of tubulogenesis54. Therefore, 
both MMPs and TIMPs participate in regulating tubulogenesis.  
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Another factor and the most researched to date, is the ability of soluble cues to induce tubulogenesis. 
It has already been stated that HGF is necessary for MDCK tubulogenesis. However, in these studies 
medium is supplemented with FBS which contain a variety of growth factors and thus, a 
combination of growth factors might be necessary to induce tubulogenesis. Importantly, the exact 
combination of factors that is responsible for proximal tubulogenesis is still unknown, as well as the 
regulatory mechanism behind ECM driven tubulogenesis. Results from several studies that 
investigated the effect of growth factors will be summarized with a focus on proximal and distal 
tubule cells, since they are the most relevant to this thesis. 
 
Similar to MDCK cells, human primary renal proximal tubular epithelial cells (RPTEC) form tubular 
structures in the presence of 20 ng/ml of HGF when cultured in collagen/Matrigel. However, 
without HGF, the cells remained rounded after 5 days. This was also seen when the medium was 
supplemented with 250 ng/ml of BMP-7, EGF, IGF-1, or follistatin, suggesting that these proteins 
do not play an active role in proximal tubulogenesis57.  The HGF induced tubulogenesis could be 
significantly increased by culturing the RPTEC containing gels in transwells with human umbilical 
vein (HUVEC) endothelial cells seeded on the bottom of the plate. The same effect was also seen 
when HUVEC conditioned medium was used instead of the co-culture system. The increase in 
tubulogenesis could not be mimicked by the addition of vascular endothelial growth factor (VEGF), 
fibroblast growth factor (FGF-2), or platelet-derived growth factor (PDGF). The HUVEC 
conditioned medium was further analyzed for the presence of MMPs and TIMPs. It was found that 
the conditioned medium contained MMP-1, TIMP-1, TIMP-2, and small amounts of MMP-2, MMP-
3, and TIMP-4. When the conditioned medium was pretreated with recombinant TIMP-1 or TIMP-2 
the enhanced tubulogenesis was reversed57.  
 
Mouse proximal tubule cells incubated with 50 ng/ml VEGF underwent tubulogenesis similar to 
HGF-treated samples58. Interestingly, they also showed that specific isoforms were involved. VEGF-
165 induced branching whereas VEGF-121 did not. This demonstrates that the mechanism behind 
tubulogenesis is highly sensitive and specific to growth factors. As the physiological environment is 
extremely complex, it is likely that the ideal condition to promote tubulogenesis involves a variety of 
growth factors. Bowes et al. found that when FGF-1, EGF, IGF-1, or FGF-7 was added to medium 
with HGF, branching and proliferation of primary rat proximal tubule cells was enhanced compared 
to cultures with HGF alone59.  The optimal condition was the combination of HGF, FGF-1, EGF, 
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and IGF-1 that led to a higher proliferation and size of branched structures. Interestingly, they also 
discovered that the addition of the sulfated glycosaminoglycan, heparin, to the medium resulted in 
the maximal HGF-induced cell proliferation. This is most likely due to heparin’s ability to bind and 
stabilize growth factors and proteins60. Overall, tubulogenesis is a complex process that can be 
modulated through extracellular matrix, proteases, growth factors, and additional factors not yet 
discovered. Further exploration into renal proximal tubulogenesis can lead to new important insights 
into the field of regenerative medicine. However, a tunable in vitro renal tubulogenesis model is 
necessary for the progress of such a study. 
 
2.2 Drug-induced nephrotoxicity 
More than 20 million people in the United States alone are estimated to have some degree of chronic 
kidney disease (CKD)1. CKD is a progressive loss of renal function that can lead to end stage renal 
disease (ESRD), and ultimately end in renal failure. It is estimated that 19-25% of all cases of severe 
acute renal failure in patients is due to drug-induced nephrotoxicity, highlighting the need for better 
preclinical assays61,62. The kidney is highly susceptible to drug toxicity, owing to its anatomy and 
function. The kidney continuously receives a large volume of blood that exposes the tissue to many 
solutes and leads to high intracellular concentrations being reabsorbed, especially in the proximal 
tubules. The proximal tubules also uptake toxic agents from the peritubular capillaries and 
metabolize drugs, xenobiotics, and other substances into toxic metabolites and reactive oxygen 
species. This process results in elevated concentration of toxins in the tubule which can cause injury 
through direct toxicity or through ischemic damage from reactive oxygen species created as 
byproducts of metabolism63. The glomerulus and the proximal tubule are the sites of more than 90% 
of drug related toxicity, as can be seen in Fig. 2.2.1B64.  
 
Current nephrotoxicity assays rely on 2D cell culture and animal models65. However, cells grown on 
conventional 2D tissue culture substrates lack the cell-cell and cell-matrix interactions of the in vivo 
environment10. For this reason, 2D cell cultures often require much higher doses of drugs to induce a 
toxic response compared to the human reaction to toxicity66. They also have a limited growth area, 
making them unsuitable for long term studies.  
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Figure 2.2.1. Nephrotoxicity in the kidney. A) Biomarkers of kidney injury for nephron specific segments. B) Drugs 
that cause toxicity in specific parts of the nephron. Graphic adapted from Bonventre et al.64  
 
In contrast, animal models provide a physiological 3D environment. However, studies have found 
that a limited number of animal experiments accurately predict the human response to drugs8,9. As a 
result, less than 10% of newly developed drugs make it past clinical trials67. Therefore, there is a 
critical need for more reliable kidney models to recapitulate the human environment. 3D cell culture 
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models are a promising alternative to conventional methods, as they can be used with human cells 
and better mimic the 3D human physiological conditions. They also allows for the analysis of 
biomarkers that have been found to indicate nephrotoxicity in vivo and the exploration of new 
biomarkers. 
 
Biomarkers are important to predict toxicity in preclinical studies to prevent nephrotoxic drugs 
entering the market and to indicate injury in humans at an early stage. Commonly used biomarkers to 
detect kidney injury in preclinical or clinical studies are serum creatinine (SCr) and blood urea 
nitrogen (BUN). However, they both have several limitations. The concentration of both biomarkers 
is controlled by many factors, which can cause a delay in detection of injury and also does not pin 
point the specific renal injury and location. SCr also cannot detect histological injury in 
nephrotoxicity preclinical studies in animals and humans64,68. BUN is a waste product from the 
metabolism of proteins. BUN levels can change based on the volume of the filtrate, exogenous 
protein loads such as protein supplementation, and endogenous catabolic states, which can all 
increase BUN levels without any kidney injury64. Therefore, these biomarkers are not specific and 
sensitive enough for the early indication of nephrotoxicity in humans or the recognition of 
nephrotoxicity in preclinical trials.   
 
For these reasons, scientists have recently been investigating novel biomarkers to detect human 
nephrotoxicity. A list of kidney injury biomarker candidates that have recently been investigated are 
shown in Fig. 2.2.1A along with the location of injury in the nephron that they detect. The 
noninvasive biomarker, kidney injury molecule (KIM-1) is of particular interest to this thesis because 
it is an early biomarker for proximal tubular damage. KIM-1 is a type 1 transmembrane protein that 
is upregulated in proximal tubule cells after injury69. The ectodomain of the protein can be shed by 
proximal tubule cells and measured from the urine during the first 12 hours of tubular injury70. KIM-
1 is highly expressed in the tissue and/or urine of experimental and clinical studies in association 
with fibrosis, inflammation, and in ischemic acute renal failure70–72. Therefore, KIM-1 may be a 
promising noninvasive biomarker for the early detection of proximal tubule injury.  
 
Many drugs are toxic to the kidney, especially the proximal tubule (Fig. 2.2.1B). Even toxins affecting 
other regions of the nephron, can still pose problems on the proximal tubules64. One drug that is 
particularly toxic is the highly potent chemotherapy drug cisplatin (cis-
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diamminedichloroplatinum(II)). Cisplatin is commonly used for the treatment of testicular, head, 
neck, ovarian, cervical, genitourinary tract, lungs, and breast, as well as other types of cancer73. 
Cisplatin is a platinum-based simple inorganic molecule that is believed to bind to DNA, forming 
crosslinks that create defective DNA templates74. This reaction stops DNA synthesis and replication. 
In cancer cells which are rapidly dividing this can induce DNA damage leading to cell death. 
Although cisplatin has been found to be a successful cancer treatment, its dosage and use is limited 
based on its cumulative nephrotoxicity and neurotoxicity75. Acute kidney injury (AKI) occurs in 20-
30% of patients treated with cisplatin76 and can cause other renal complications such as 
hypomagnesemia, fanconi-like syndrome, distal renal tubular acidosis, hypocalcemia, renal salt 
wasting, renal concentrating defect, hyperuricemia, transient proteinuria, erythropoietin deficiency, 
thrombotic microangiopathy, and chronic renal failure76. There is a higher risk of nephrotoxicity in 
cisplatin-treated patients with higher doses and frequency and have the following characteristics: 
older age, female, smoker, hypoalbuminemia, and pre-existing renal insufficiency76. 
 
Cisplatin is particularly toxic to the renal proximal tubules, which accumulates a concentration of 
cisplatin that is 5 times more than the serum concentration, which contributes to its toxicity in the 
cells77,78. Two membrane transporters have been identified as responsible for the uptake of cisplatin 
in proximal tubule cells, Ctr1 and OCT2. Ctr1 is a high affinity copper transporter that is localized to 
the basolateral membrane of the proximal tubule and is also responsible for the partial uptake into 
cancer cell lines74. OCT2 is an organic cation transporter that is also located on the basolateral 
membrane of the proximal tubule cell and plays a role in cellular uptake of cisplatin74. 
Overexpression of OCT2 in human proximal tubular cells resulted in increased uptake and sensitivity 
to cisplatin and the OCT2 inhibitor, cimetidine, has been shown to decrease cisplatin uptake in renal 
tubular cells79.  
 
The mechanism of cisplatin induced nephrotoxicity is a complicated process that involves multiple 
pathways. In vitro, it was found that low doses of cisplatin induces apoptosis in proximal tubular cells 
whereas high concentrations led to necrosis80. However, nephrotoxic doses in vivo lead to an 
increased level of both apoptosis and necrosis in the kidney76. Once in the cell, cisplatin undergoes 
metabolic activation into more potent toxins. While still in the blood circulation, cisplatin forms 
glutathione conjugates. They are then cleaved to cysteinyl-glycine-conjugates by gamma glutamyl 
transpeptidase (GGT) expressed on the surface of proximal tubule cells and then subsequently, 
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metabolized to cysteine-conjugates by aminodipeptidases on the proximal tubule cells. These 
cysteine-conjugates then enter into the proximal tubule cells and are further metabolized by cysteine-
S-conjugate beta-lyase to highly reactive thiols76. This reaction then causes injury in the tubular and 
oxidative stress as a result from the reaction, as a result inflammation ensues, followed by vascular 
injury in the kidney81. Understanding the pathway of cisplatin-induced nephrotoxicity is important 
for identification therapeutic treatments to inhibit its nephrotoxic effects, potentially through 
inhibiting one of the crucial stages of cisplatin metabolism. 3D renal models offer a promising way to 
study this mechanism in vitro where the effects can be easily monitored. The next section will cover 
the current state of biomaterial-based kidney models. 
 
2.3 3D in vitro biomaterial-based renal models  
As briefly mentioned in earlier sections, there is a critical need for more reliable and representative 
human renal models that can be used for the study of renal tubulogenesis, as well as nephrotoxicity. 
The ideal model would recapitulate the human 3D structure and function of proximal tubules in a 
robust matrix that can be easily analyzed in throughput screenings for toxicity or regenerative 
medicine applications. There are several approaches to obtaining the ideal 3D renal model including 
kidney organoids from stem cells, natural and synthetic hydrogels, kidney-on-a-chip, 3D printing, 
and decellularized scaffolds. Keeping with the concept of the thesis, this section will focus on the 
advantages and disadvantages of kidney organoids and tubule models in natural and synthetic 
biomaterials.   
 
Recent progress in the generation of kidney organoids from human stem cells can be considered 
highly promising for creating more realistic human in vitro models82–85. Organoids utilizing induced 
pluripotent stem cells have great potential in personalized medicine because they can easily be 
obtained compared to primary renal cells that can only be acquired invasively. Freedman et al. 
formed tubular organoids by culturing human pluripotent stem cells in between two layers of 
Matrigel. The cells formed cavitated spheroids in the Matrigel and after a change of media and 
addition of glycogen synthase kinase-3β (GSK3β) inhibitor (Chiron Technologies 99021 - 
CHIR99021) and B27 supplement, the spheroids disaggregated and formed tubular organoids. The 
role of Matrigel is unclear in the system and was not thoroughly investigated.  
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The report by Freedman et al. showed very exciting data for the use of stem cells in creating renal 
organoids for toxicity and disease modeling using CRISPR/Cas9 gene editing84. However, the 
tubular structures that formed were much larger than human proximal tubules in vivo and the culture 
also contained a distribution of non-renal cells, which can potentially disrupt results. Interestingly, in 
the reported manuscript, they compared induced pluripotent stem cells with embryonic stem cells 
and found that induced pluripotent stem cells led to a lower differentiation efficiency into tubular 
organoids than human embryonic stem cells84. A possible reason for this is that induced pluripotent 
stem cells can retain epigenetic characteristics of their somatic tissue of origin86. Although embryonic 
stem cells have high differentiation purity, they cannot be used in personalized medicine and ethical 
aspects restrict their application. In addition, pluripotent stem cells, in general, carry the risk of 
teratoma formations in vivo 84,87,88. Also, the use of stem cells in a culture model adds additional 
differentiation steps that prolongs the culture time. Another important factor for the study of renal 
regenerations is that stem cells, especially embryonic stem cells, recapitulate the developmental 
kidney nephrogenesis rather than portraying how adult renal cells respond to stress and stimuli. For 
these reasons, the application of primary renal tubule cells for renal models is advantageous for 
models of adult nephrotoxicity and renal regeneration. 
 
An alternative to organoid models, are tubule/tubulogenesis models with differentiated renal cells 
that offer a more simple and straightforward culture. Previously described 3D renal tubulogenesis 
models use reconstituted collagen I, Matrigel™, or a combination of these materials40,41,49,57,59,89–93. 
The first renal tubulogenesis model was reported in 1991 which established a tubulogenesis model 
using MDCK cells resuspended in collagen I matrix with the addition of fibroblast conditioned 
medium or HGF to the culture40,41. Since then, this model has been extensively investigated and 
revealed important factors that contribute to renal tubulogenesis, which is described in Section 2.1.3. 
While this method was the gold standard for many years, it is not the ideal model to study human 
proximal tubulogenesis. This is because of two main factors: 1) MDCK cells are from canine which 
can vary to human cells and 2) MDCK are derived from the distal tubule or collecting duct of the 
nephron and therefore, have different functions and potentially different tubulogenic mechanisms 
than proximal tubules.  
 
To create a model that is more representative of proximal tubules, some studies have used primary 
proximal tubule cells or a heterogeneous population of human renal cells embedded in collagen I or 
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a mixture of collagen I and Matrigel57,94,95. While these matrices support the growth of renal tubular 
cells, the formed tubular structures do not accurately portray the size and/or functions of the human 
proximal tubule. They generate tubule-like structures that are orders of magnitude smaller than in vivo 
human proximal tubules and also offer limited evidence of a clear lumen57. Similar to the MDCK 
model, the primary proximal tubule models often require the addition of HGF, EGF, or FBS to the 
medium to stimulate tubulogenesis57,59,95,96.  
 
DesRochers et al. embedded immortalized human renal cortical cells in a matrix made of a 50:50 
mixture of Matrigel and collagen I.  The mixed population of renal cells formed small tubule-like 
structures after 2 weeks in culture in the Matrigel/collagen mixture. The model was used to 
systematically compare nephrotoxicity outcomes in 3D versus 2D cell culture89,97. They reported 
better overall function of cells in 3D and found that the 3D model was more sensitive to 
nephrotoxins, supporting the belief that 3D models are a better representation of the in vivo 
environment. However, even after 4 and 8 weeks of culture, the branched structures remained small, 
with only a 1 or 2 cell diameter and there was no evidence of a lumen shown89.  
 
One of the disadvantages of using naturally derived biomaterials is that they often have batch-to-
batch variations which inhibit the reproducibility of the cultures. They are also difficult to handle, 
requiring cold temperatures and adjustment of pH(with collagen gels) that make them suboptimal for 
high throughput screening. Moreover, these materials lack tunability in mechanical and biofunctional 
properties, which is required for testing the impact of exogenous signals on renal tubulogenesis. 
 
Synthetic matrices could circumvent the problems of naturally derived matrices by offering 
controlled, tunable material characteristics that can be customized to stimulate renal tubulogenesis. 
To date, the only synthetic hydrogel used as a renal model was reported in 2012 by Astashkina et al. 
and was made with hyaluronic acid(HA) and poly(ethylene glycol) diacrylate (PEGDA)98,99. This 
report showed that synthetic hydrogels have the potential to maintain murine tubule tissue for long 
term culture. Proximal tubule fragments were digested from murine kidneys and embedded in the 
HA-PEGDA hydrogel. The murine tubules retained function (cathepsin B, alkaline phosphatase, and 
gamma glutamyltransferase) when cultured in the hydrogels. The model was also tested for 
application as a nephrotoxicity assay by incubating the hydrogel samples with cisplatin, doxorubicin, 
and 4-aminophenol, which resulted in increased levels of inflammatory cytokine release.  
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This HA-PEGDA model was a huge development in the field by showing the many functional tests 
and applications that can be utilized with 3D renal models. However, the model is not clinically 
relevant because proximal tubules cannot be extracted from living humans and results gathered from 
mouse tubules can contain interspecies differences. In addition, the model does not provide a model 
for tubulogenesis and the growth of structures was not shown. Therefore, it has limited use for 
investigating pro-tubulogenic factors for regenerative medicine.  
 
Although these studies have been important breakthroughs in the field of 3D models, the optimal 
renal tubulogenesis model has not yet been established. The ideal renal tubulogenesis model would 
accurately recapitulate the structure, size, and function of the proximal tubules. The model should 
employ a tunable matrix where physical and biomolecular parameters can be independently 
investigated to allow for investigating renal regenerative therapies and disease modeling. A renal 
tubulogenesis model that functions similar to in vivo human proximal tubules could also be used as a 
reliable nephrotoxicity model, limiting the need for animal models. Work presented in this thesis will 
show the use of in situ forming starPEG-heparin hydrogels as a renal tubulogenesis model. A 
summary of the characteristics of starPEG-heparin hydrogels will be described in the following 
section.  
 
2.4 In situ forming starPEG-heparin hydrogels 
In this thesis, biohybrid hydrogels were used to create an in vitro 3D renal tubulogenesis model. The 
hydrogels are composed of two components, the synthetic, flexible polymer, four-armed 
poly(ethylene glycol) (starPEG) and the glycosaminoglycan, heparin. This hydrogel platform has 
been successfully employed as a cell culture model for a variety of cell types100–103. PEG is a 
hydrophilic, hydrolytically non-degradable, non-toxic polymer that is highly soluble in water, making 
it useful for various biomaterial applications. Additionally, PEG undergoes only limited metabolism 
in the body and whole polymer chains can be eliminated either through the kidneys by glomerular 
filtration if their molecular mass is less than 30 kDa and through the liver when molecular mass is 
greater than 30 kDa104. Also, the terminal groups of PEG can be easily modified with functional 
groups making it a versatile building block for biomaterials.  
 
The other main component of the hydrogel network is heparin, a glycosaminoglycan composed of 
repeating disaccharide units containing iduronic acid and glucoasmine. Heparin is only found in small 
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amounts in the human body105. However, it has a similar structure to heparan sulfate which is 
endogenously located on the surfaces of mammalian cells and a common component of the 
extracellular matrix60. Heparan sulfate contains less sulfation groups than heparin. However, heparin 
is more often used for biomaterial applications because it is readily available.  
 
Due to its high content of sulfation groups, heparin has the highest negative charge of any biological 
macromolecule60. The high negative charge allows it to electrostatically bind and stabilize numerous 
positively charged growth factors and proteins. Heparin also contains adhesion sites for a variety of 
growth factors such as HGF, HB-EGF, and FGF-2. Moreover, heparin has the ability to bind to 
extracellular matrix (ECM) molecules, such as collagen IV, one of the main components of the renal 
basement membrane50,106,107. Altogether, using heparin as a building block in hydrogels can create a 
more in vivo-like environment for cell culture. 
 
To create three-dimensional (3D) cultures for embedding cells, in situ forming biohybrid hydrogels 
were formed by covalently crosslinking starPEG and heparin through Michael-type addition. This 
reaction is beneficial because it has no side products, does not require a catalyst, and takes place 
quickly under physiological conditions108,109. Heparin is first functionalized with maleimide for such a 
reaction. The carboxylic groups on the heparin are activated by 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) and N-hydroxysulfo-succinimide (sNHS) which creates a sNHS-heparin ester. 
This then reacts with the amine group on the N-(2-aminoethyl)maleimide which forms heparin-
maleimide conjugates (Fig. 2.3.1 top panel). Using this method, up to 8 maleimide groups can be 
attached to the back bone of heparin. Commercially available thiol-end-functionalized starPEG is 
then mixed with the maleimide-functionalized heparin, where the Michael-type addition reaction 
takes place. Specifically, acting as a nucleophile, the thiol group of the starPEG shares electrons with 
the carbon-carbon double bond of the maleimide group on the heparin. This creates a covalent bond 
between the starPEG and heparin and allows for the formation of a crosslinked network (i.e. 
hydrogel)(Fig. 2.3.1 bottom panel)110.  
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Figure 2.3.1. Schematic describing starPEG-heparin hydrogel synthesis. Top panel shows the functionalization 
steps of heparin to form heparin-maleimide conjugates. Middle panel how starPEG can be functionalized with ECM 
peptides (SIKVAVGWCG) and MMP-cleavable peptides (GCGGPQGIWGQGCQ). Adapted from Tsurkan et al110. 
Copyright permission granted by John Wiley and Sons Publishing Group. 
 
A key advantage of starPEG-heparin hydrogels over other hydrogel systems used as cell scaffolds is 
its ability to bind and release growth factors and cytokines111. Another advantage of the hydrogel is 
the ability to decouple the physical and biomolecular characteristics to investigate their individual 
effects on cell behavior. The crosslinking density of the hydrogel and consequently, the bulk 
mechanical properties, can be modulated by easily adjusting the molar ratio of starPEG to heparin 
(γ). By keeping the heparin concentration constant, the mechanical properties can be tuned 
independently of the biomolecular properties of the hydrogel. The maleimide on the heparin can be 
further functionalized with cell-adhesion sites such as Arg-Gly-Asp (RGD) containing peptides to 
further replicate the in vivo environment and promote cell adhesion110. To further imitate the 
extracellular matrix, the starPEG component can be functionalized with ECM peptides like laminin 
or collagen (Fig. 2.3.1 middle panel)110. A MMP cleavable peptide sequence can also be attached to 
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starPEG to allow cells to degrade and remodel the matrix, similar to how they would in vivo (Fig. 
2.3.1). 
 
As already alluded to, heparin makes starPEG-heparin hydrogels advantageous due to its ability to 
modulate growth factor and cytokine sequestration, stabilization, protection, and sustainable release 
112–116. Several studies have shown the successful adhesion and release of growth factors111,113. Relating 
to the scope of this thesis, heparin has been previously reported to govern the release and bioactivity 
of growth factors (FGF-2) from proximal tubule epithelial cells114 and decrease fibrosis and 
inflammation in models of renal disease117,118. The binding and release of growth factors and 
cytokines can be further modulated by the removal of sulfation groups on the heparin119. 
 
Overall, starPEG-heparin hydrogels offer a highly tunable system that is ideal for probing cell 
behavior in in vitro cell models. This hydrogel platform has already been shown to be successful as a 
an in vitro breast cancer model, a mammary epithelial model, and an angiogenesis model100,101,103. The 
broad range of modulation allows the hydrogels to be further functionalized to continuously explore 
a single cell type or population of cells. For these reasons, starPEG-heparin hydrogels could have 
great potential as a renal tubulogenesis model. With this biohybrid hydrogel platform, mechanics, 
growth factor/cytokine presentation, ECM peptides, and degradability can be independently 
investigated to determine their effect on renal tubulogenesis. These results could provide important 
insights for the field of renal regenerative medicine. In addition, tubule structures generated in 
starPEG-heparin hydrogels could be used for nephrotoxicity assays and disease modeling.  
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Chapter 3 
Materials and Methods 
3.1 Preparation of hydrogel networks 
For cell experiments, 25 μl hydrogel drops were formed on a hydrophobic microscope slide coated 
with Sigmacote®(Sigma-Aldrich, Munchen, Germany). After polymerization, the hydrogel was 
moved to a 24 well plate containing 1 ml of medium. Gel discs were used for rheology by forming 67 
μl gels in between two 9 mm Sigmacoted coverslips. After polymerization, both cover slips were 
removed and the resulting hydrogel discs were swollen in cell culture medium. All phosphate 
buffered saline (PBS) used for hydrogel preparation was supplemented with 1% 
penicillin/streptomycin (P/S). For growth factor binding studies, 25 μl hydrogels were formed in low 
protein binding eppendorfs (Protein LoBind Tube, Eppendorf AG, Germany). All materials used 
and methods for peptide and conjugate synthesis can be found in the Appendix (Chapter 6). 
 
3.1.1 Formation of starPEG-heparin hydrogels 
Hydrogels were fabricated as previously described110. All hydrogel material was dissolved in 
phosphate buffered saline (PBS) with 1% P/S. In brief, heparin-maleimide (MW = 10,000) was 
dissolved in ¼ of the total gel volume. Proximal tubule cells were then added to the heparin-
maleimide solution in ¼ of the total gel volume to make 2 x 106 cells/ml (50,000 cells/gel). Thiol 
end-functionalized four arm starPEG (MW=10,000, JenKem Technology, China) or starPEG-MMP 
was dissolved in ½ of the total gel volume. The cell/heparin solution was then mixed with the 
starPEG/starPEG-MMP solution to form a 25 μl hydrogel. Gelation time of the hydrogels was ~30 
seconds. For all cell experiments, a 25 μl gel was cast onto a microscope slide coated with 
Sigmacote® (Sigma) for 20 min at room temperature. After polymerization, the gels were then moved 
to a 24 well plate with warm media. The stiffness of the hydrogel was modulated by varying the 
molar ratio (γ) of starPEG/starPEG-MMP to heparin from 0.63 to 1.5. Synthesis of starPEG-MMP 
and heparin-maleimide conjugates can be found in the Appendix (Chapter 6). 
  
  Materials and Methods 
 
31 
 
3.1.2 Formation of starPEG-MMP-starPEG hydrogels 
Degradable starPEG-MMP-starPEG gels were formed in a similar manner as starPEG-heparin 
hydrogels. Specifically, starPEG-MMP was dissolved in ¼ of the total gel volume and then mixed 
with the cells.  StarPEG-end terminated with a maleimide group (starPEG-mal) was dissolved in ½ 
of the total gel volume and subsequently the pH was adjusted to 4-5. The solution was then mixed 
with the starPEG-MMP/cell mixture to form the hydrogels. 
 
3.1.3 Formation of Matrigel samples 
For Matrigel samples, cells were centrifuged, resuspended with Matrigel™(BD Science), and then 
cast on microscope slide at 50 μl/gel. A 50 μl Matrigel volume was used because of its comparable 
size to starPEG-heparin hydrogels after swelling. Cell embedded-Matrigel was then incubated at 
37°C for 20 min and then transferred to warm media. Each Matrigel gel contained 50,000 cells.  
 
3.1.4 Rheometric measurement of hydrogel discs 
Hydrogels were swollen in cell culture media overnight at 37°C. Oscillating rheology measurements 
were then performed on a rotational parallel plate rheometer (ARES LN2, TA Instruments, 
Germany) at 25°C, as described previously120. Frequency sweeps were performed with a shear 
frequency range of 101 – 102 rad s-1 at 10% strain. The mean storage modulus was then calculated. 
 
3.1.5 HGF functionalization of starPEG-heparin hydrogels 
StarPEG-MMP-heparin hydrogels were functionalized with HGF using standard hydrogel 
preparation protocols followed in Section 3.1.2. Recombinant human HGF (Peprotech, Germany) 
was diluted to 100 μg/ml. During gel formation, HGF was added to the heparin-maleimide in 1/8 of 
the total gel volume. For the 25 μl gels used in these studies, heparin-maleimide was first dissolved in 
PBS in 1/8 of the total gel volume. The heparin-maleimide solution was then mixed with HGF 
diluted to 1/8 of the total gel volume by pipetting, resulting in ¼ of the total gel volume. During this 
time HGF can bind to heparin-maleimide through known binding sites and/or electrostatic 
interactions. The HGF-heparin solution was then mixed by pipet with HK-2 cells that were 
resuspended in ¼ of the total gel volume. 14 μl of the resulting solution was then mixed with 14 μl 
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of dissolved starPEG-MMP to form 25 μl gels. The hydrogels were cast on sigmacoted slides and 
then transferred to wells after polymerization. 
 
3.1.6  Binding of HGF in HCS to hydrogels using Multiplex assay 
To identify the amount of HGF in blood serum and how it binds to hydrogels, human umbilical 
cord serum was incubated with the hydrogels. Due to the lack of bovine antibodies, human umbilical 
cord serum (HCS; Human cord serum pooled, Lee Biosolutions, Inc., USA) was used as an 
alternative serum source. HGF was measured in 100% serum or 10% serum diluted in DMEM 
medium to stimulate cell culture experiments. Solutions were made in low protein binding 
eppendorfs or centrifuge tubes coated with bovine serum albumin to prevent unspecific protein 
binding. StarPEG-heparin hydrogels with 18 μl volume were formed at the bottom of 0.5 ml protein 
LoBind eppendorf tube (Eppendorf AG). Two hydrogel crosslinking densities were used 0.63 and 
1.0, referred to as gel 1 and gel 2, respectively in the results. Collagen gels were also formed as a 
control at the following a concentration of 0.9 mg/ml and 3 mg/ml referred as collagen 1 and 
collagen 2, respectively. An additional control was made with soluble unfunctionalized heparin. For 
this control, 0.55 mg heparin, which is the amount in each starPEG-heparin hydrogel, was added to a 
0.5 ml protein low bind eppendorf tube and mixed with the respective solution by pipetting. For 
immobilization of the analyte to the material, 300 μl of HCS containing solution was incubated with 
the hydrogel material, soluble heparin, or alone for 24 hours at room temperature. After the 
incubation, the solution was removed and immediately frozen at -80°C for later analysis. For 
cytokine quantification, samples were thawed and analyzed for HGF concentration using a human 
cancer 8-Plex-kit (Bio-Rad) measured with the Bio-Plex 200 System (Bio-Rad) according to the 
manufacturer’s instructions. 
 
3.2 Culture of proximal tubule epithelial cells 
3.2.1 Cultivation of human proximal tubule cell lines 
HK-2 human kidney proximal tubule epithelial cells (ATCC CRL-2190) were cultured in DMEM/F-
12 media (Gibco) supplemented with 10% fetal bovine serum (FBS, Biochrom) and 1% 
penicillin/streptomycin (P/S) solution. Conditionally immortalized proximal tubule epithelial cells 
(ciPTEC) were generously donated by Prof. Roos Masereeuw (Radboud university medical center, 
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Nijmegen, The Netherlands) and Dr. Martijn Wilmer (Radboud university medical center, Nijmegen, 
The Netherlands). ciPTEC were isolated from urinary sediment of a healthy donor and immortalized 
with SV40T and hTERT, as previously described121. ciPTEC were grown for proliferation at 33°C in 
DMEM-Ham’s F-12 media(Gibco) phenol red free, supplemented with 5 μg/ml insulin(Sigma), 5 
μg/ml transferrin (Sigma), 5 ng/ml selenium (Sigma), 36 ng/ml hydrocortisone (Sigma), 10 ng/ml 
EGF (Sigma), 40 pg/ml tri-iodothyronine (Sigma), and 10% FBS. For maturation, ciPTEC were 
transferred to 37°C.  
 
3.2.2 Cultivation of primary human proximal tubule cells 
Primary human renal proximal tubule epithelial cells were purchased from American Type Culture 
Collection (ATCC, #PCS-400-010). Primary tubule cells were cultured in the same media as ciPTEC, 
but supplemented with 0.5% FBS instead of 10%. Primary tubule cells were used for experiments at 
passages 2-4. Culture medium was changed every 2-3 days for all cell experiments. 
 
3.3. In vitro assays 
3.3.1 Tubulogenesis quantification 
Three phase contrast images were taken from each hydrogel, weekly for 4 weeks (n=3 
hydrogels/condition). At least 80 colonies from each gel were manually counted and categorized 
according to their stage of tubulogenesis which was categorized as round spheroids, spheroids with 
processes (“spiny spheroids”), or tubular structures. The values of all gels in the experiment were 
summed together and percent of tubulogenesis was quantified. The experiments were then averaged 
together which is shown in the presented graphs. Experiments were performed in triplicate and 
differences between experiments are shown with standard deviation. Colonies were considered to be 
tubules when their length to diameter ratio was greater than 5. Tubulogenesis results are expressed as 
percentage of total colonies counted.  
 
3.3.2 Shape and size analysis of renal structures  
After 4 weeks in culture, phase contrast images were acquired and area, perimeter, and circularity of 
colonies were quantified using Image J software (NIH, USA). Circularity measurement determines 
the roundness of an object where a value of 1.0 indicates a perfect circle and a value approaching 0.0 
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indicates an elongated structure. Three phase contrast images were acquired from each hydrogel and 
three hydrogels were made per condition. For starPEG-heparin and starPEG-MMP-starPEG 
samples, 20 structures per image were analyzed and for starPEG-MMP-heparin hydrogels, 10 
structures per image were analyzed. This is due to the difference in structure size, in starPEG-MMP-
heparin hydrogels, the large structures resulted in an average of 10 colonies per image. Colonies from 
one experiment were pooled together and summed for the area or perimeter analysis and averaged in 
the case of the circularity measurement. The total value for the experiment was then averaged with 
the totals from other experiments to get the value in the presented graphs. The difference between 
experiments is shown with standard deviation. Experiments performed in triplicate. 
   
3.3.3 Metabolic activity assay 
Metabolic activity was assessed by PrestoBlue assay. A 1:10 dilution of PrestoBlue Reagent 
(ThermoFisher Scientific) in warm media was added to each sample. Samples were incubated at 37°C 
for 2 hours. Then 100 μl of solution was transferred in duplicate into a 96 well plate for detection. 
Fluorescence was measured using a Tecan Genios plate reader (Tecan Deutschland GmbH) at an 
excitation wavelength of 560 nm and an emission wavelength of 590 nm.  When comparing different 
matrices, hydrogels in each condition were first moved to a new 24 well plate to eliminate effects of 
cells outside of the hydrogels. 
 
3.3.4 Cytotoxicity assay (LDH release) 
LDH secretion was measured in cell culture supernatant using the LDH cytotoxicity assay (Takara, 
USA), following the manufacturer’s instructions. Supernatant was taken from each sample in 
replicates of 3. Reaction mixture was incubated with supernatant for 15-20 minutes at room 
temperature and then absorbance was measured using a Tecan Genios plate reader (Tecan 
Deutschland GmbH). The positive control group was treated with 1% Triton X-100 to measure the 
maximum LDH release from 100% dead cells. 
 
3.3.5 Organic anion transport assay 
Transepithelial transport was analyzed by incubating the hydrogel cultures with the fluorescent 
organic anion, Lucifer Yellow(LY).  After 4 weeks in culture, media was changed to DMEM-Ham’s 
F-12 media(Gibco) phenol red free, supplemented with 5 μg/ml insulin(Sigma), 5 μg/ml transferrin 
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(Sigma), 5 ng/ml selenium (Sigma), 36 ng/ml hydrocortisone (Sigma), 10 ng/ml EGF (Sigma), 40 
pg/ml tri-iodothyronine (Sigma), and 0.5% FBS. Samples were imaged with confocal and then 
Lucifer Yellow CH dilithium salt (Sigma, 100 μM) was added to media and incubated with the 
hydrogels for 1h. For washout experiments, media with LY dye solution was removed, replaced with 
dye free media, incubated for 20h, and then imaged with confocal microscopy. 
 
3.3.6 Nephrotoxicity Assay 
After 4 weeks in culture, media was removed on hydrogel samples and replaced with serum-free 
media containing 0 to 100 μM cis-Diammineplatinum (II) dichloride (cisplatin, Sigma) for 48 hours. 
A 2 mM stock solution of cisplatin was made by dissolving 6 mg of cisplatin in 10 ml of MilliQ 
water. The stock solution was vortexed and sonicated for 10-20 minutes until the majority of the 
powder was dissolved. The stock solution was then diluted further in MilliQ water to make solutions 
of 0.5 mM, 1.0 mM, 1.5 mM, and 2 mM. Finally, 50 μl of each cisplatin solution was added to a 
single well of a 24 well plate containing 950 μl of serum free DMEM/F-12 medium, making a final 
concentration of 25, 50, 75, and 100 μM. MilliQ water was added to control wells at the same 
volume. After incubation with the drug, metabolic activity and cytotoxicity were measured 
(Metabolic activity and cytotoxicity assays described in sections 3.3.3 and 3.3.4, respectively). 
Expression of the renal injury biomarker, KIM-1, and apoptotic cells were analyzed through 
immunofluorescence.  
 
3.4. Microscopy techniques 
3.4.1. Phase contrast microscopy 
For standard analysis of cell culture and image acquisition for the quantification of tubulogenesis and 
tubular structures, a Leica inverted microscope (Leica DMIL, Leica Microsystems, Germany) with 
Leica application software (LAS software, Leica Microsystems, Germany) was used. All non-
fluorescent images of renal structures are greyscale phase contrast micrographs.  
 
3.4.2. Fluorescent staining 
Samples were fixed in 4% performaldehyde for 20 min. Samples were washed 2 times with PBS and 
then immunostained immediately or embedded in OCT solution and snap-frozen on dry ice for 
  Materials and Methods 
 
36 
 
cryosectioning. Samples were blocked with 5-10% goat or donkey serum in PBS or PBS with 0.5% 
Triton X-100 for 1 hour and then incubated overnight with primary antibodies at 4°C. After 3 
washes with PBS/0.1% Triton X/1% donkey or goat serum, secondary antibodies were incubated 
for 1 hour at room temperature. The following primary antibodies were used: mouse anti-β-Catenin 
(610153, BD Transduction Laboratories, 1:100), rabbit anti-active caspase-3 (ab2302, Abcam, 1:100), 
mouse anti-Ki67 (1:100), rabbit anti-KIM-1 (NBP1-76701, Novus Biologicals, 1:100), rabbit anti-
laminin (L9393, Sigma, 1:50), goat anti-collagen IV (1340-01, Southern Biotech, 1:50), and rabbit 
anti-ZO-1 (40-2200, Invitrogen, 1:100). Secondary antibodies purchased from Invitrogen or Life 
Technologies include: Alexa Flour 488 goat anti-rabbit (1:100 or 1:200), Alexa Flour 633 goat anti-
mouse (1:200), donkey anti-mouse 488, donkey anti-goat 488 (1:200), goat anti-mouse 488 (1:200), 
goat anti-rabbit 633 (1:200). For actin staining, Phalloidin-Atto 633 (68825, Sigma, 1:50) was applied 
during secondary antibody incubation. Samples were washed and incubated with Hoechst 33342 
nuclear dye (Life Technologies) for 20-30 minutes. Resulting samples were then washed 3 times with 
PBS and imaged. 
 
3.4.3. Confocal microscopy 
All fluorescent images were acquired using a Leica confocal SP5 microscope (Leica Mikrosysteme 
Vertrieb).The following oil objectives were used to acquire images: 20x, 40x, or 63x. Images were 
captured at 100 or 400 Hz at a resolution of 1024 x 1024 pixels. For the organic anion transporter 
assay, phase contrast images were also simultaneously acquired using the Leica confocal microscope.  
 
3.4.4. Transmission Electron Microscopy (TEM) 
Proximal tubule cell-laden hydrogels were cultured for 4 weeks and then fixed in modified 
Karnovsky’s fixative (2% glutaraldehyde + 2% paraformaldehyde in 50 mM HEPES) for at least 
overnight at 4°C. They were washed 2x in 100 mM HEPES and 2x in water, postfixed in 1% 
OsO4/water for 2hrs on ice, washed several times with water, and en bloc contrasted/postfixed with 
1% uranyl acetate/water for 2 hours on ice. The samples were then washed several times in water, 
dehydrated in a graded series of ethanol/water up to 100% ethanol, infiltrated in epon 812 
(epon/ethanol mixtures: 1:3, 1:1, 3:1 for 1.5 hours each, pure epon overnight, pure epon 3 hours), 
embedded in flat embedding molds and cured at 65°C. Ultrathin sections were prepared with a Leica 
UC6 ultramicrotome (Leica Microsystems, Vienna, Austria), collected on formvar-coated slot grids, 
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stained with lead citrate and uranyl acetate as previously described,122 and analyzed on a FEI 
Morgagni D268 transmission electron microscope (FEI, Eindhoven, The Netherlands) at 80 kV 
acceleration voltage. All TEM images and processing after the fixation step were performed by Dr. 
Thomas Kurth (CRTD, Dresden, Germany). 
 
3.5 Statistical Analysis 
Sample size was chosen based on the reproducibility and variability of specific experiments. Samples 
were only excluded from analysis if they were incubated with assay buffer (ex. LDH reaction 
mixture) longer than other samples in the same plate due to mechanical error. For all experiments, 
the same number of cells was embedded in each hydrogel (50,000 cells/hydrogel). For 
nephrotoxicity studies, experimental (cisplatin treated) and control wells were chosen at random 
from previously formed hydrogels. Fields and samples for imaging and quantification were chosen at 
random for all experiments. Investigators were not blinded to the conditions during the experiments 
or data analysis. All statistics were performed using GraphPad Prism 5 (GraphPad Software Inc.). 
Multiple samples were analyzed using a one-way analysis of variance (ANOVA) and Tukey’s multiple 
comparison post-hoc test. To evaluate statistical differences among multiple samples with different 
parameters, a two-way analysis of variance (ANOVA) and Bonferroni post-hoc test were applied. 
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Chapter 4 
Results and discussion 
4.1 Characterization of hydrogel-based tubulogenesis model 
The first aim of the thesis was to find the optimal conditions for 3D culture of proximal tubule cells 
in a hydrogel. To do this, single human immortalized proximal tubule cells (HK-2 cells) were 
embedded in a range of hydrogel conditions. HK-2 cells were chosen because they have previously 
been shown to retain many characteristics of primary human proximal tubule epithelial cells, as well 
as respond to nephrotoxins123–125. Seeding concentrations, mechanical properties, and hydrogel 
components were systematically varied to find the ideal parameters for the renal tubulogenesis 
model.  
 
4.1.1 Optimization of cell seeding concentration in 3D culture 
The number of cells seeded in culture can make a significant impact on their morphogenesis through 
paracrine and cell-cell adhesion affects31,126. To determine the optimal seeding concentration to 
promote the fastest rate of proximal tubulogenesis, two seeding concentrations of HK-2 cells were 
tested, a “high concentration” of 6 x 106 cells/ml (150,000 cells/gel) and a “low concentration” of 2 
x106 cells/ml (50,000 cells/gel). Due to the known influence of MMPs on renal tubulogenesis 
(discussed in Section 2.1.3), a MMP cleavable peptide was used as a crosslinker in the starPEG-
heparin hydrogels; these hydrogels will be referred to throughout the thesis as starPEG-MMP-
heparin hydrogels. The MMP cleavable peptide allows the proximal tubule cells to degrade and 
remodel the hydrogel matrix through the release of their MMPs.  
 
Tubulogenesis was quantified using nomenclature applied in a previous study, where colonies were 
classified according to their stage of tubulogenesis; round spheroids were called “smooth spheroids”, 
spheroids with extensions, a precursor of tubules, were called “spiny spheroids,” and tubules were 
termed “tubular structures”40. Colonies were considered to be tubular when their length to diameter 
ratio was greater than 5. In the degradable starPEG-MMP-heparin hydrogels, tubulogenesis was 
slightly higher in the low cell concentration throughout the study (Fig. 4.1.1. AB). By day 11, there 
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were significantly less smooth spheroids and more spiny spheroids in the low cell concentration (Fig. 
4.1.1. C-E). Therefore, the low cell concentration promotes increased tubulogenesis compared to the 
high cell concentration and hence, the low cell concentration was used for all following experiments.  
These results are counter-intuitive, as it would be expected that more cells would leader to a faster 
rate of tubulogenesis. However, in MMP cleavable hydrogels, proximal tubule cells need to release 
the adequate amount of MMPs to cleave the hydrogel matrix at a suitable time frame that allows for 
tubulogenesis, while keeping the hydrogel still intact. A possible explanation for the lower rate of 
tubulogenesis with the high cell concentration is that the higher number of cells led to more 
degradation of the hydrogel. Consequently, this would result in a softer hydrogel which was perhaps 
not conducive to tubulogenesis. The next studies explored this idea further by specifically examining 
the mechanical effects of the hydrogel on tubulogenesis.  
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Figure 4.1.1. Effect of seeding concentration on renal tubulogenesis. HK-2 cells were cultured in starPEG-MMP-
heparin hydrogels at either a “High cell concentration” (6 x106 cells/ml) or a “Low cell concentration” (2 x106 cells/ ml). 
Tubulogenesis was quantified every two days for the high cell concentration (A) and the low cell concentration (B). Their 
representative phase contrast images at day 11 are shown below (C, D, respectively). Scale bar, 100 µm. n=3, Mean ± s.d. 
(E) Tubulogenesis quantification at 11 days to compare between high and low cell concentrations. Mean ± s.d., *P<0.05. 
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4.1.2 Optimal hydrogel mechanical properties to promote renal tubulogenesis 
Numerous studies have revealed the influence of mechanical properties on the survival and 
proliferation of cells in culture127–129. For example, Chen et al. found that both the chemical 
composition and physical properties of a matrix influence the differentiation of mouse proximal 
tubule cells seeded on 2D substrates. Specifically, they found that soft matrices (<1 kPa) promoted 
the preservation of the epithelial phenotype of proximal tubule cells. They also observed that a 
normal mouse kidney, measured using Bio-AFM, had an elastic modulus of 300 Pa, although this 
was an unpublished observation130.   
 
For these reasons, it was important to explore the effect of the hydrogel’s mechanical properties on 
proximal tubule cells and find the optimal stiffness to promote tubulogenesis. To do this, HK-2 cells 
were embedded in starPEG-MMP-heparin hydrogels with a range of mechanical properties. The 
stiffness of the hydrogels was tuned by changing the crosslinking degree as previously described101,110. 
The crosslinking density is expressed as a molar ratio (γ) of starPEG-MMP to heparin and can be 
adjusted by changing the ratio of the two components. StarPEG-MMP-heparin hydrogels were 
formed with a crosslinking degree (γ) of 0.75 to 1.5. The hydrogels were then measured with a 
rheometer to find the storage modulus. The rheology data showed that storage modulus (stiffness) of 
the hydrogels increased with increasing crosslinking density (Fig. 4.1.2.). These results agree with the 
previous report by Tsurkan et al that also employed starPEG-MMP-heparin hydrogels110. 
 
 
Figure 4.1.2. Mechanical properties of starPEG-MMP-heparin hydrogels with different crosslinking densities. 
The crosslinking degree is expressed as a molar ratio (γ) of starPEG to heparin. The storage modulus (stiffness) was 
measured with a rheometer (Mean ± s.d.).  
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The same hydrogel conditions were then applied to cell culture. HK-2 cells were embedded in 
starPEG-MMP-heparin hydrogels with crosslinking densities of 0.75, 1.0, 1.25, and 1.5 with 
mechanical properties corresponding to Fig. 4.1.2. Tubulogenesis was quantified in the same manner 
as described in Section 4.1.1. After 3 weeks in culture, the most tubular structures were observed in 
the hydrogel with the lowest crosslinking degree (γ = 0.75) (Fig. 4.1.3A). The stiffest hydrogel (γ = 
1.50) had the least amount of cell colonies that showed signs of tubulogenesis (Fig. 4.1.3.D). The 
second softest hydrogel (γ = 1.0) had more than 50% of colonies that underwent tubulogenesis by 
week 3 (Fig. 4.1.3B). However, this condition did not promote the growth of tubular structures 
within the duration of the study. Taken together, it was concluded that matrices with a storage 
modulus <1 kPa are optimal for promoting renal tubulogenesis. For future cell studies, hydrogels 
were made with these mechanical properties. 
 
These findings agree with the previously mentioned paper from Chen et al. which found that softer 
matrices were ideal for proximal tubule cells and prevented their dedifferentiation131. Unfortunately, 
the results cannot be directly compared to the human kidney because of the limited data on kidney 
stiffness in the literature. However, one study has used magnetic resonance elastography (MRE) to 
measure the shear modulus of the kidney. They found a gradient of stiffness within the kidney with 
the cortex, the region where the majority of proximal tubules reside, to be ~4.35 kPa132.  
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Figure 4.1.3 Effect of hydrogel mechanical properties on renal tubulogenesis. Tubulogenesis was quantified 
throughout a 3 week culture. HK-2 cells were embedded in starPEG-MMP-heparin hydrogels at the following 
crosslinking degrees: 0.75 (A), 1.0 (B), 1.25 (C), 1.50 (D)(Mean ± s.d.). The mechanical properties that correspond to 
these hydrogels are shown in Fig. 4.1.2. 
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4.2 Evaluating the effect of hydrogel matrix on PTECs 
Once the optimal conditions were established, the influence of individual hydrogel components on 
renal proximal tubulogenesis was investigated. HK-2 cells were embedded in three hydrogel variants 
consisting of covalent polymer networks of heparin and/or starPEG, formed as previously 
described100,101,110. To allow the cells to degrade and remodel the hydrogel matrices, a matrix 
metalloproteinase (MMP) cleavable peptide was attached to the starPEG, as in previous experiments. 
To explore the influence of heparin and cleavable peptide linkers on renal tubulogenesis, the 
following conditions were investigated: non-degradable starPEG-heparin hydrogels (without MMP 
cleavable peptide), degradable starPEG-MMP-starPEG hydrogels (without heparin), and degradable 
starPEG-MMP-heparin hydrogels. 
 
4.2.1 Influence of hydrogel components on renal tubulogenesis 
To create a comparable system, all polymer hydrogels were synthesized with the same mechanical 
properties (storage modulus of 500 Pa) so that the effect of the composition of the material could be 
independently investigated (Fig. 4.2.1). Also, all heparin-containing hydrogels had the same amount 
of heparin (0.56 mg/hydrogel) to have similar biomolecular properties between hydrogels. By 
keeping the biophysical and biomolecular properties stable between the three hydrogel variants, we 
were able to determine the unique effect of each hydrogel composition on renal tubulogenesis. 
Matrigel™, a commercially available reconstituted basement membrane, was used as a control. 
Matrigel is composed of the extracellular matrix components, laminin, collagen IV, heparan sulfate, 
entactin, and vitronectin, and is commonly used in studies to coat tissue culture plates or embed cells 
in 3D matrices49.  
 
Tubulogenesis was quantified over a time course of 4 weeks as described in Section 4.1.1. In 
degradable starPEG-MMP-starPEG hydrogels, proximal tubule cells formed unorganized, round 
structures (Fig. 4.2.2A), whereas in the non-degradable starPEG-heparin hydrogel, they remained as 
single cells or formed smooth, round spheroids (Fig. 4.2.2B). Remarkably, in degradable starPEG-
MMP-heparin hydrogels, HK-2 cells underwent tubulogenesis and formed complex branched tubule 
structures by week 4 (Fig. 4.2.2C). Tubulogenesis in starPEG-MMP-heparin hydrogels was 
significantly higher than the other hydrogel conditions (Fig. 4.2.2D).  
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Figure 4.2.1. Comparable mechanical properties of tested hydrogel variants. The storage modulus (stiffness) of 
each hydrogel condition that was used in cell studies was measured by rheometry (Mean ± s.d., n=2-3/condition, 
measurements performed in triplicate, values not significant (n.s.)).   
 
To further characterize the renal structures in each hydrogel condition, the circularity, surface area, 
and perimeter of the structures were measured manually using Image J. Circularity is a measurement 
of roundness where 1.0 corresponds to a perfect circle. The average circularity of renal structures in 
starPEG-heparin hydrogels was 0.98, whereas structures in starPEG-MMP-heparin hydrogels were 
significantly less circular, due to their more elongated, tubular structures (Fig. 4.2.2C and Fig. 4.2.3). 
Renal structures in starPEG-MMP-starPEG hydrogels were less organized which led them to be less 
circular than structures in starPEG-heparin hydrogels; however, they were still significantly more 
circular than starPEG-MMP-heparin hydrogels (Fig. 4.2.2A,E). Renal structures in starPEG-MMP-
heparin hydrogels were also significantly larger than the other hydrogel conditions (Fig. 4.2.2F, G).  
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Figure 4.2.2. Comparative evaluation of HK-2 cell tubulogenesis and generated renal structures in three 
hydrogel variants. Quantification of tubulogenesis in the following hydrogel conditions: starPEG-MMP-PEG (A), 
starPEG-heparin (B), and starPEG-MMP-heparin (C) (Mean ± s.d., n=3/condition). Representative phase contrast 
images of the corresponding hydrogels are seen below. Scale bar, 100 μm. (D) Compiled tubulogenesis quantification 
from week 4. (Mean ± s.d., ***P<0.001 compared to starPEG-heparin and starPEG-MMP-starPEG hydrogels). (E) 
Average circularity of structures in each hydrogel condition, where 1 corresponds to a perfect circle (Mean ± s.d., 
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n=3/condition, ***P<0.0005. (F) Surface area of renal structures in each hydrogel condition (Mean ± s.d., 
n=3/condition, **P<0.01). (G) Perimeter of renal structures in each hydrogel condition (Mean ± s.d, n=3/condition, 
***P<0.001).  
 
To verify that heparin was crucial to promote renal tubulogenesis in the hydrogel system, HK-2 cells 
were embedded in degradable starPEG-MMP-starPEG hydrogels (without heparin) with a range of 
mechanical properties from 100-500 Pa, correlating to the choice of solid content during gel 
formation. No signs of tubulogenesis were seen in the starPEG-MMP-starPEG hydrogels (Fig. 
4.2.3A). In addition, the softest hydrogel with 2% solid content, was fully degraded by week 4 and 
showed no signs of tubulogenesis before gel degradation. Therefore, both heparin and a cleavable 
matrix linker are essentially needed in our hydrogel system to stimulate renal proximal tubulogenesis. 
 
 
Figure 4.2.3. HK-2 cells embedded in starPEG-MMP-starPEG hydrogels with varied mechanical properties. 
HK-2 cells were embedded in starPEG-MMP-hydrogels with 2, 2.5, and 3% solid content. A) Representative phase 
contrast images after 4 weeks in culture.  StarPEG-MMP-starPEG hydrogels with 2% solid content were fully degraded 
by week 4. Scale bar, 200 μm. B) Rheology measurements of starPEG-MMP-starPEG hydrogels showing the storage 
modulus for the solid contents that were used in cell studies. 
 
As a control, HK-2 cells were also embedded in Matrigel, a reconstituted basement membrane from 
Engelbreth-holm-Swarm mouse sarcoma. Matrigel, has been seen to promote the growth of kidney 
cells in several studies alone or as a mixture with collagen I 90,91,96,130. In our studies, HK-2 cells were 
embedded in Matrigel under similar conditions as starPEG-heparin hydrogels, with 50,000 cells 
embedded per gel. HK-2 cells formed unorganized structures in Matrigel, similar to renal structures 
in starPEG-MMP-starPEG hydrogels (Fig 4.2.4). This finding agrees with the study by Santos et al. 
which showed that MDCK cells cultured in Matrigel with HGF did not form branching tubular 
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structures like they did in collagen I gels49. By dissecting the ECM components in Matrigel and 
independently testing them on tubulogenesis, they found that laminin, entactin, and fibronectin 
induced the formation and complexity of tubular structures and collagen IV, heparin sulfate 
proteoglycan, and vitronectin, inhibited tubular formation. Therefore, it is possible that the amount 
of these inhibitory ECM components, are presented too high in Matrigel to allow for proximal 
tubule formation. 
 
 
 
Figure 4.2.4. Representative image of HK-2 cells cultured in Matrigel. HK-2 cells were embedded in Matrigel in 
the same conditions as for synthetic hydrogels. Phase contrast image taken after 4 weeks in culture. Scale bar, 100 μm. 
 
To test the reproducibility of this model, the study was repeated with a second cell line, conditionally 
immortalized human proximal tubule epithelial cells (ciPTEC). CiPTEC were isolated from urinary 
sediment of a healthy donor and immortalized with SV40T and hTERT, as previously described121. 
This allows them to be maintained for at least 45 passages when grown at 33°C. When cultured at 
37°C for 10 days, ciPTEC express multiple drug transporters and maintain morphological 
characteristics of the native human proximal tubule121. CiPTEC cells were embedded in the three 
synthetic hydrogel variants under the same conditions as HK-2 cells, with 50,000 cells/hydrogel. 
 
Results from ciPTEC studies showed a similar trend of forming round spheroids in non-degradable 
starPEG-heparin hydrogels and significantly more tubule structures in the degradable starPEG-
MMP-heparin hydrogels (Fig. 4.2.5A,B), confirming the results from HK-2 cells. CiPTEC cells 
formed smaller tubule-like structures than HK-2 cells after 4 weeks in culture; this could be due to 
their difference in origin. CiPTEC cells were isolated from urinary sediment whereas HK-2 and 
primary proximal tubule cells were obtained from human tissue121,123. Another difference between 
ciPTEC and HK-2 cells was seen in degradable starPEG-MMP-starPEG hydrogels, where ciPTEC 
spontaneously underwent apoptosis after a few days in culture. This could be caused from the pH of 
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starPEG-maleimide that needs to be adjusted to 4-5 to decrease the time of gelation when forming 
starPEG-MMP-starPEG hydrogels. CiPTEC cells resemble human primary proximal tubule cells at 
37°C and hence, are inherently more sensitive than traditional cell lines. Therefore, it is possible that 
the low pH in the starPEG-maleimide solution directed them to undergo apoptosis. CiPTEC had a 
significantly higher metabolic activity in degradable starPEG-MMP-heparin hydrogels compared to 
other hydrogel conditions (Fig. 4.2.5C). Taken together, ciPTEC results confirm that the hydrogel-
based model is reproducible with other proximal tubule epithelial cells.  
 
 
Figure 4.2.5. Comparative evaluation of ciPTEC cells embedded in three different hydrogel variants. 
Tubulogenesis quantification of ciPTEC cells in non-degradable starPEG-heparin(A) and non-degradable starPEG-
MMP-heparin (B) (Mean ± s.d., n=3-4/condition, >100 colonies/condition, experiments performed in duplicate). 
Representative phase contrast images of ciPTEC cells after 4 weeks in culture seen below. Tubulogenesis was not 
quantified in starPEG-MMP-starPEG hydrogels due to cell death. Scale bar, 200 μm. (C) Metabolic activity of ciPTEC 
cells after 4 weeks in culture (Mean of pooled experiments ± s.e.m., n=3-4/condition, experiments performed in 
duplicate; ***P<0.0001). 
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4.2.2 Effect of hydrogel components on cell viability 
To further understand how the hydrogel components affect proximal tubule cells, metabolic activity 
and lactate dehydrogenase (LDH) release were measured after HK-2 cells were cultured in the 
hydrogels for 4 weeks. Metabolic activity is the sum of the chemical reactions that occur in a cell. 
LDH is an enzyme released by cells following damage to the plasma membrane, and can be used to 
quantify necrotic cells133.  Hence, it is often used in cytotoxicity assays. 
 
Metabolic activity of HK-2 cells was significantly higher in degradable starPEG-MMP-heparin 
hydrogels compared to all other hydrogel conditions (Fig. 4.2.6A), similar to ciPTEC cells (Fig. 
4.2.5C). This data suggests that cell activity is increased from hydrogels incorporated with heparin 
and MMP-cleavable peptides, which could contribute to their resulting tubulogenesis. HK-2 cells in 
Matrigel had a significantly higher metabolic activity than starPEG-MMP-starPEG and starPEG-
heparin hydrogels (Fig. 4.2.6A). Matrigel consists of natural ECM components from an animal 
source and it is therefore, not surprising that it induces a higher metabolic activity compared to 
synthetic hydrogels. Interestingly, with the addition of heparin and a cleavable matrix, it was possible 
to engineer a hydrogel that promotes higher metabolic activity than a natural ECM derived hydrogel 
(Fig. 4.2.6A).   
 
HK-2 cells cultured in degradable starPEG-MMP-heparin hydrogels also had significantly less LDH 
release than starPEG-MMP-starPEG and Matrigel conditions. Although starPEG-heparin hydrogels 
had a low metabolic activity, they also had a significantly low LDH release. It is possible that because 
the HK-2 cells in starPEG-heparin hydrogels are unable to degrade the matrix, it triggers them to 
become quiescent which results in a lower metabolic activity. It is interesting that the two hydrogels 
containing heparin have the lowest LDH release. However, it is important to note that starPEG-
MMP-starPEG hydrogels and Matrigel had the most cells that evaded the hydrogels and grew on the 
bottom of the tissue culture plate, potentially contributing to their high LDH levels. They also were 
the only samples where media changed to yellow in between media changes, signifying a change in 
pH. 
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Figure 4.2.6. Metabolic activity and LDH release of HK-2 cells in response to synthetic and naturally derived 
hydrogels. HK-2 cells were embedded in hydrogels and cultured for 4 weeks. A) Metabolic activity measured with 
PrestoBlue assay (Mean of pooled experiments ± s.d., n =3/condition, experiments performed in triplicate, 
***P<0.0001, starPEG-MMP-heparin significant vs. all other conditions). B) Cytotoxicity measured by lactate 
dehydrogenase (LDH) levels in supernatant after 4 weeks in culture (Mean of pooled experiments ± s.d., n=2-
3/condition, experiments performed in duplicate, ***P<0.0001). 
 
To more closely understand the viability of the renal structures, the amount of proliferating and 
apoptotic cells in the structures was analyzed. Renal structures from each hydrogel condition were 
stained with Ki67, a proliferation marker, and cleaved caspase-3, a marker of apoptosis. Tubule 
structures in degradable starPEG-MMP-heparin hydrogels contain multiple proliferative cells, and 
limited apoptotic cells (Figure 4.2.7). Spheroids in starPEG-heparin hydrogels showed more 
apoptotic cells than other conditions that localized to the lumen (Fig. 4.2.7). The formation of 
lumens by apoptosis is a common mechanism that has previously been observed in the generation of 
cysts and tubules46. Therefore, the increase of apoptotic cells in spheroids is most likely due to this 
process. Surprisingly, although starPEG-MMP-starPEG hydrogels promote the formation of 
unorganized colonies, their structures contain both proliferating and apoptotic cells, signifying that 
the matrices support the growth of proximal tubule cells, although they do not contain any 
biomolecular properties to stimulate tubulogenesis. 
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Figure 4.2.7. IF of proliferation and apoptotic markers in renal structures after 4 weeks in culture. Confocal 
images showing the expression of the proliferation marker, Ki67, and the apoptotic marker, cleaved caspase-3 in 
representative structures in each hydrogel condition. Insets are magnified views of structure. Scale bar, 75 μm. Inset scale 
bar, 25 μm. 
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4.2.3 Evaluation of polarization and architecture of renal structures 
The in vivo human proximal tubule is characterized by a polarized, cuboidal epithelium, with many 
mitochondria on the basal side, Golgi apparatus localized to the apical side, a primary cilium, and a 
brush border made up of microvilli that faces the lumen of the tubule21,134. These characteristics are 
portrayed in Fig. 4.2.8.  
 
  
 
Figure 4.2.8. Schematic of polarized proximal tubule and a representative cell. Cilium, Golgi, M, mv, and N represent 
primary cilium, Golgi apparatus, mitochondria, microvilli, and the nucleus, respectively. 
 
To evaluate polarization and morphology, renal structures in all three synthetic hydrogel conditions 
were analyzed by transmission electron microscopy (TEM) and IF. Renal structures were evaluated 
for the previously mentioned signs of polarization. TEM can capture images at significantly higher 
resolution than light microscopes. Using this technique, we were able to examine the ultrastructure 
of the cells. HK-2 cells were embedded in the three hydrogel conditions and then cultured for 4 
weeks. They were then fixed and processed for TEM imaging which can be seen more in detail in 
Materials and Methods section.  
 
In degradable starPEG-MMP-starPEG hydrogels, HK-2 cells showed no signs of polarization with 
cells forming unorganized structures with no lumens (Fig. 4.2.9A). In contrast, in starPEG-heparin 
hydrogels, HK-2 cells formed spheroids with lumens, often filled with cell debris (Fig. 4.2.9B). These 
cells had a cuboidal-like epithelial phenotype, however, not all Golgi apparatuses were localized to 
the apical side (Fig. 4.2.9B) or are fully aligned(Fig. 4.2.10A), but they did contain some microvilli 
(Fig. 4.2.10B). Interestingly, tubular structures formed in degradable starPEG-MMP-heparin 
hydrogels had a cuboidal epithelium with clear lumens, Golgi apparatus localized to the apical side, 
and basal mitochondria (Fig. 4.2.9C and Fig. 4.2.10E). The tubules did not possess a brush border 
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but did contain some microvilli, as well as primary cilium (Fig. 4.2.10C-E). Remarkably, these 
generated tubular structures recapitulated the diameter of human proximal tubules which published 
reports observed to have a diameter of 30-60 μm23,135. In addition, the height of the HK-2 cells in the 
tubular structure in Fig. 4.2.9C was measured (using Image J) to be ~9 μm, whereas the average cell 
height in physiological human proximal tubules is ~8 μm135. Therefore, the tubular structures 
generated in starPEG-MMP-heparin hydrogels recapitulate the physiological size of the human 
proximal tubule. 
 
 
Figure 4.2.9. Electron micrographs of generated renal structures in three different hydrogel variants. HK-2 cells 
were cultured in 4 weeks in (A) degradable starPEG-MMP-starPEG, (B) non-degradable starPEG-heparin, and (C) 
degradable starPEG-MMP-heparin hydrogels with progressive magnifications of selected regions below. Scale bar of 
enlarged region, 10 μm. Scale bar of magnified regions, 1 μm. Cilium, Golgi, M, mv, and N represent primary cilium, 
Golgi apparatus, mitochondria, microvilli, and the nucleus, respectively. 
 
A few structures in starPEG-MMP-heparin hydrogels did not have the thick cuboidal cells like 
shown in Figure 4.2.9 but were thinner and stretched around a lumen. Remarkably, these structures 
have a strong resemblance to the squamous epithelia of the thin limb of the loop of Henle 
(Appendix Fig. 7.1). It is possible that the source of HK-2 cells contain a small pool of cells from the 
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loop of Henle since HK-2 cells are originally isolated from heterogeneous tissue of the kidney 
cortex123,136. It is fascinating that within a heterogeneous population of cells, cells with the same 
phenotype migrate to each other in the hydrogels and form structures mimicking their in vivo 
architecture. These results strongly suggest that proximal tubule cells and other tubular epithelial cells 
of the nephron have an inherent ability to undergo tubulogenesis which can be stimulated with 
starPEG-MMP-heparin hydrogels. In the future, it would be interesting to embed a heterogeneous 
mixture of renal tubule epithelial cells in the starPEG-MMP-heparin hydrogels to evaluate the 
generated structures and see if structures from the different cell types attach together to form a 
physiologically-relevant nephron tubule. 
 
 
Figure 4.2.10 Electron micrographs of the ultrastructure of HK-2 cells cultured in hydrogels. HK-2 cells were 
cultured in non-degradable starPEG-heparin hydrogels (A, B) and degradable starPEG-MMP-heparin hydrogels (C-F). 
Electron micrographs show the ultrastructure of cells after 4 weeks in culture. Cilium, Golgi, M, mv, and N represent 
primary cilium, Golgi apparatus, mitochondria, microvilli, and the nucleus, respectively. Scale bars, 1 μm 
 
To determine if HK-2 cell derived renal structures form cell-cell junctions, a further characteristic of 
polarization, structures were stained for β-catenin. β-catenin is a protein associated with the 
cytoplasmic region of E-cadherin and plays a role in cell-cell adhesion. It is located basolaterally on 
polarized proximal tubule cells. Renal structures in each hydrogel condition were stained for β-
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catenin after a culture time of 4 weeks. β-catenin could be seen on the basolateral sides of HK-2 cells 
in tubule structures in starPEG-MMP-heparin hydrogels and in spheroids in starPEG-heparin 
hydrogels (Fig. 4.2.11). The protein could also be seen in cells in colonies formed in starPEG-MMP-
starPEG hydrogels, although the staining might be slightly less uniform. These results support the 
study by Chung et al. that found that PEG hydrogels with a similar MMP cleavable peptide promote 
the formation of unorganized colonies of MDCK cells. Specifically, the MDCK cell-derived colonies 
had an inverted polarization and less defined lumens compared to colonies in PEG hydrogels 
functionalized with laminin or RGD137. These results support the data from this thesis that show that 
additional cell attachment sequences are needed to promote the formation of polarized structures.  
 
To further evaluate the architecture of the structures, it was necessary to determine if renal basement 
membranes similar to native proximal tubules were present. The renal basement membrane is an 
important part of the proximal tubule and has been shown to have a role in differentiation, cell 
adhesion, and filtration50. To explore if HK-2 cells created their own extracellular matrix in vitro, the 
renal structures were stained for collagen IV and laminin, the main components of the proximal 
basement membrane50. Collagen IV and laminin could be seen around the perimeter of renal 
structures in starPEG-heparin and starPEG-MMP-heparin hydrogels (Fig. 4.2.12). Surprisingly, 
unorganized structures in starPEG-MMP-starPEG hydrogels also had collagen IV around structures, 
but had noticeably less laminin than other conditions (Fig. 4.2.12).  
 
This data suggests that all hydrogels promote an environment where HK-2 cells can create their own 
ECM. The ECM was localized on the outside of the structures, similar to the renal basement 
membrane in vivo, which coats the outer surface of the tubule. The ECM was mostly uniformly 
distributed around spheroids in starPEG-heparin conditions. This could be due to their more simple 
structure, which also makes them easier to image compared to tubule structures in starPEG-MMP-
heparin hydrogels. Although these findings suggest that HK-2 cells formed a basement membrane in 
vitro, this has not been confirmed by TEM images and so a conclusion cannot be made. More 
magnified TEM images should be taken to fully elucidate the presence of a full basement membrane.  
However, from this data we can say that the cells create their own ECM in the hydrogels and are 
more polarized in heparin-containing hydrogels. The only condition that generated polarized tubule 
structures that resembled the polarization and architecture of the in vivo proximal tubule was the 
degradable starPEG-MMP-heparin hydrogels. For these reasons, it was determined that starPEG-
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MMP-hydrogels are the optimal matrix for a tubulogenesis model and future studies were conducted 
using this condition.  
 
 
Figure 4.2.11. IF of polarization markers of renal structures after 4 weeks in culture. Confocal  images showing the 
basolateral marker, β-catenin, in representative structures in each hydrogel condition. Insets are magnified views of 
structure. Scale bar, 75 μm. Inset scale bar, 25 μm. 
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Figure 4.2.12. IF of extracellular matrix deposition after 4 weeks in culture. Confocal  images showing 
representative HK-2 cell-derived structures in each hydrogel condition. Insets are magnified views of structure. Scale bar, 
75 μm. Inset scale bar, 25 μm.  
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4.3 Effect of soluble cues on renal tubulogenesis 
Tubulogenesis is a complex process that involves the coordination of various soluble factors such as 
cytokines, growth factors, proteases, and extracellular matrix components. From the previous studies 
it has been determined that the optimal hydrogel composition to promote renal tubulogenesis is the 
degradable starPEG-MMP-heparin hydrogels. Having fully established and characterized the 
hydrogel model, it was then used to explore tubulogenesis to show the versatile capabilities of the 
model and demonstrate that it can potentially be used for developmental biology, disease modeling, 
and regenerative medicine applications.  
 
4.3.1 Influence of growth factors in FBS on tubulogenesis 
Fetal bovine serum (FBS) is the blood fraction that remains after the coagulation of whole blood and 
the separation from red blood cells via centrifugation. It contains a complex mixture of proteins, 
growth factors, hormones, nutrients, trace elements, and is a common supplement to cell culture 
media44. The various factors are often essential for the growth and maintenance of cells in vitro. The 
purpose of this study was to determine if fetal bovine serum was required to promote renal 
tubulogenesis using the established hydrogel model and if so, are the growth factors in serum the 
stimulating components. 
 
The first study was designed to conclude if fetal bovine serum had an effect on renal tubulogenesis 
in the starPEG-MMP-heparin hydrogels. Three concentrations of FBS were applied to the cultures: 
0, 5, and 10%. HK-2 cells were embedded in the hydrogels and the samples were cultured for 3 
weeks. Tubulogenesis was quantified weekly and metabolic activity was measured at 3 weeks. In the 
0% FBS condition, tubulogenesis did not occur, with the majority of cells (91%) remaining rounded 
by week 3 (Fig. 4.3.1A). In both FBS treated conditions, HK-2 cells underwent tubulogenesis (Fig. 
4.3.1A). By week 3, samples with 10% FBS had an overall higher tubulogenesis than 5% FBS when 
spiny spheroids, precursors of tubules, were taken into account (Fig. 4.3.1B). Samples with 5% and 
10% FBS had significantly less smooth spheroids and significantly more spiny spheroids compared 
to the 0% FBS control (Fig. 4.3.1B). Therefore, FBS has a direct effect on renal tubulogenesis. 
 
As expected, FBS also had a significant impact on the metabolic activity of HK-2 cells embedded in 
the degradable hydrogel model. A concentration dependent response was shown with both 5% and 
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10% FBS having a significantly higher metabolic activity compared to the 0% control, and 10% FBS 
having the highest effect (Fig. 4.3.1C). This agrees with many studies where FBS was reported to 
support growth, increase size, and/or stimulate proliferation of a range of cell types138–141. The FBS-
induced increase in metabolic activity could contribute to the higher rate of tubulogenesis seen in the 
FBS-treated hydrogels by stimulating the cells to be more active, thereby forming tubule structures. 
Other studies have also shown the that the presence of FBS or specific growth factors stimulates 
renal tubulogenesis in 3D cultures57,95,142. Although FBS contains many proteins such as adhesion 
proteins, extracellular components, and hormones that have all been shown to effect cell 
behavior143,144, it is hypothesized that growth factors in the serum are key modulators of 
tubulogenesis in culture. 
 
 
Figure 4.3.1. Influence of fetal bovine serum on renal tubulogenesis and metabolic activity. Tubulogenesis was 
quantified over  a time course of 3 weeks (A) (Mean ± s.d., n=3). B) Compiled tubulogenesis at week 3 (Mean ± s.d., 
n=3, ***P<0.001, *P<0.05). C) Metabolic activity at week 3 (Mean ± s.d., n=3, **P<0.005, *P<0.05). 
 
To test this hypothesis and further understand the specific components in FBS that contribute to 
renal tubulogenesis, a serum substitution experiment was performed. To do this, panexin NTA, a 
serum substitute from PAN Biotech GmbH, was added to the culture. Panexin NTA is a chemically 
defined composition of purified proteins, lipids, salts, amino acids, trace elements, attachment 
factors, and hormones that simulate serum composition. The substitute does not contain any growth 
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factors, therefore, it can be used to determine if the presence of growth factors in the serum play a 
role in stimulating renal tubulogenesis.  
 
Panexin NTA was added to DMEM/F-12 medium with 1% P/S at 10% v/v. 10% FBS was used as 
a control. The medium for both conditions came from the same bottle to ensure that all other 
experimental factors were the same. In addition, all of the cells used in the study were from the same 
passage. The samples were monitored over time and tubulogenesis was quantified. After 1 week in 
culture, the majority of HK-2 cells with the serum substitute remained round with only about 25% 
progressing to spiny spheroids (Fig. 4.3.2A). However, by week 2 cells with NTA looked unhealthy 
with signs of cell death, resulting in the amount of round cells increasing. For this reason, 
tubulogenesis was not quantified at week 3 for the NTA condition. On the contrary, HK-2 cells with 
10% FBS in the medium displayed the usual evolution of tubulogenesis, comparable to results from 
the previous FBS study (Fig. 4.3.2A).  
 
 
Figure 4.3.2. Effect of serum substitute on renal tubulogenesis. NTA is a commercially available serum substitute 
that contains no growth factors. A) Tubulogenesis quantification. (Mean ± s.d., n=3 condition, >100 colonies/condition) 
(B) Metabolic activity of HK-2 cells after 4 weeks in culture (Mean ± s.d., n = 3, *P<0.05.). 
 
Metabolic activity was also measured at week 3 to determine the effect of serum growth factors on 
cell activity. Proximal tubule cells in FBS treated samples were significantly more metabolically active 
(~10 times more) than NTA samples (Fig. 4.3.2B). It should also be noted that hydrogels in the 
NTA condition were much softer at the end of the study and 2 out of 3 hydrogels were degraded 
and contained dead cells. The probable reason for this is that cells without growth factors underwent 
programmed cell death, potentially necrosis. Necrosis is caused by physico-chemical stress and is 
characterized by cytoplasmic swelling, plasma membrane damage, and organelle breakdown145. Upon 
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membrane damage, the cellular contents can seep out into the extracellular environment. Therefore, 
if HK-2 cells underwent necrosis they would have released their extracellular contents, which would 
include MMPs. Proximal tubule cells have been shown to produce MMP-2, 3, 7, 9, 14, and 24146. As 
previously mentioned, starPEG-MMP-heparin hydrogels contain a degradable peptide with the 
sequence GPQG↑↓IWGQ which is cleavable by MMP-1, 2, 3, 7, 8, and 9147. Thus, it is probable that 
when HK-2 cells become necrotic they release MMPs that degrade the hydrogel matrix, contributing 
to the hydrogels being softer, compared to hydrogels that were cultured with FBS. 
 
From these serum studies, it was determined that the growth factors in FBS are necessary to 
maintain HK-2 cell viability and promote tubulogenesis in the hydrogel-based renal model. These 
results agree with findings from Sakurai et al. that show that multiple growth factors modulate 
tubulogenesis in vitro148. The growth factors HGF, EGF, insulin growth factor(IGF-1), and fibroblast 
growth factor (FGF-2) have all been seen to have a positive impact on tubulogenesis and have all 
been found in serum149–151. Sakurai et al found that a growth factor mix and mouse embryonic kidney 
cell conditioned media were the only conditions to promote UB cells to form tubules, whereas single 
growth factors alone did not have the same effect148. 
 
4.3.2 Influence of HGF on tubulogenesis and its binding to hydrogels 
The previous results showed that growth factors are needed in the hydrogel model to instigate renal 
tubulogenesis. Now that 10% FBS was found to be the optimal condition to promote tubulogenesis, 
it was important to next determine if tubulogenesis could be further modulated through the addition 
of growth factors to the culture.  
 
HGF, also known as scatter factor, is a protein found in serum that has been demonstrated to 
stimulate the growth of proximal tubule cells in vitro42. It is a high molecular weight (70-100 kDa) 
heparin-binding protein that stimulates epithelial proliferation, motility, morphogenesis, and 
angiogenesis in various organs42,152. It has also been seen to have a major role in renal tubulogenesis. 
Several studies have found that tubule cells embedded in collagen I matrices required HGF to 
undergo tubulogenesis41,59. When HGF was not added to the cultures, the tubule cells remained 
rounded. Therefore, the established hydrogel-based renal tubulogenesis model presented in this 
thesis is already an improvement on prior naturally based ECM models made with collagen and 
  Results and Discussion 
 
63 
 
Matrigel. The goal of this experiment was to determine if the addition of HGF to our system would 
increase the growth of proximal tubule cells and lead to a faster rate of tubulogenesis.  
 
Bowes et al. found that the concentration of HGF that enhanced maximal proliferation of primary 
renal proximal tubular rat cells in a collagen matrix was between 5-20 ng/ml59. Consequently, three 
HGF concentrations were chosen on the same range, 2, 20, and 200 ng/ml. HGF was added both to 
the hydrogels upon fabrication and in the media throughout the culture period to limit the diffusion 
of HGF out of the hydrogels.  HGF was embedded in the hydrogels by premixing with the heparin-
maleimide solution. HGF contains heparin binding sites and so upon mixing, it binds to the heparin 
and can then be released from the hydrogel over time. The HGF-heparin solution was then mixed 
with the HK-2 cells and subsequently mixed with starPEG-MMP to form the hydrogels, following 
the standard protocol. HGF was added to DMEM/F-12 medium with 1% P/S and 10% FBS. The 
medium was changed every 3 days and the study was in culture for 2 weeks.  
 
 
Figure 4.3.3. Effect of HGF on renal tubulogenesis. HGF was embedded in the hydrogels at 4 different 
concentrations: 0, 2, 20, and 200 ng/ml. A) Tubulogenesis quantification of HK-2 cells at week 2 (Mean ± s.d., n=2-
3/condition, >100 colonies/condition, **P<0.01, *P<0.05). B) Metabolic activity of HK-2 cells at week 2 (Mean ± s.d, 
n=3/condition, **P<0.01, *P<0.05). 
 
Tubulogenesis was quantified and is displayed in Fig. 4.3.3A. The only HGF concentration that 
stimulated a significant increase in tubulogenesis was the highest concentration, 200 ng/ml. Samples 
with 200 ng/ml had significantly more spiny spheroids than the control (0 ng/ml HGF) and 
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significantly less smooth spheroids compared to all conditions (Fig. 4.3.3A). There was no substantial 
difference between the control (0 ng/ml HGF) and 2, and 20 ng/ml HGF.  
 
Metabolic activity of HK-2 cells in the HGF treated cultures was also measured at week 2. Results 
show that HGF triggered a concentration dependent increase in metabolic activity (Fig. 4.3.3B). The 
highest concentration of HGF applied (200 ng/ml) resulted in HK-2 cells that had a significantly 
higher metabolic activity compared to the control and 2 ng/ml HGF. These results agree with 
findings from Bowes et al. where HGF induced a concentration dependent increase in metabolic 
activity, measured by MTT assay, when added to the culture of primary rat proximal tubule cells 
embedded in collagen59.  They also found that when applied separately to media with 10% FBS, 
HGF led to significantly more cells than the FGF-1, EGF, IGF-1, FGF-7, and TGF-β1 when added 
alone. Interestingly, when HGF was combined with other growth factors, there was an induced 
proliferation compared to the concentration of HGF alone. Therefore, it is possible that combining 
HGF with another growth factor would induce an increase in proliferation and tubulogenesis. These 
studies were performed using 20 ng/ml HGF.  However, in the starPEG-MMP-heparin hydrogel 
tubulogenesis model, 20 ng/ml HGF did not illustrate a change in tubulogenesis. One potential 
reason for this is that HGF contains high affinity binding sites to heparan sulfate and heparin, 
whereas collagen I has low affinity binding sites for HGF153,154.  
 
The structure and amount of HGF binding in the system can contribute to the bioactivity of the 
growth factor. For example, Sakata et al. found that in the presence of heparin, HGF has an 
increased tendency to oligomerize153. If this oligomerization is important for signal transduction, then 
the addition of heparin to the system could affect the bioactivity of HGF153. Indeed, Bowes et al. 
found that the addition of 10 μg/ml heparin to 3D collagen cultures initiated the maximal HGF-
induced proximal cell proliferation59. Although the concentrations of 2 and 20 ng/ml did not affect 
tubulogenesis in the established model, it did affect the metabolic activity of the cells. Therefore, it is 
possible that although the rate of tubulogenesis was only changed with the highest concentration, 
HGF might have altered the amount of branches or size of the structures. Unfortunately, this was 
not quantified but futures studies could be done to see how HGF affects tubule branching and size 
in the hydrogels.  
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To better understand how HGF from serum interacts with the hydrogels, a growth factor binding 
study was performed with the hydrogels. Unfortunately, the amount of HGF in FBS cannot 
currently be measured due to a lack of bovine antibodies and so, umbilical cord blood serum was 
used for the study. It is assumed that this concentration would be similar in FBS, as several studies 
have revealed that umbilical cord serum can be used to replace FBS in in vitro cultures of foreskin 
fibroblasts, mesenchymal stem cells, and endothelial cells155–157. The measured concentration of HGF 
in human umbilical cord blood was found by Patki et al. to be 2.5816 ± 0.10828 ng/ml151. To 
confirm these results, this experiment was repeated in our lab using a Multiplex assay, where it was 
found that serum contained ~2 ng/ml HGF (Fig. 4.3.4). It should be noted that this was repeated 
with a second batch of cord serum that contained a HGF concentration of 1.3 ng/ml(data not 
shown), which confirms literature that states serum has batch-to-batch variations, which can alter 
results158. Nevertheless, it is useful to understand the approximate amount of HGF in serum and 
how it interacts with starPEG-heparin hydrogels.  
 
To simulate the HK-2 cell experiments, 10% serum in DMEM medium was also measured. The 
samples were measured fresh at time 0 and after 24 hours incubation at room temperature. For 
100% serum samples, the HGF level increased after 24 hours, this occurred for both batches of 
serum tested. A possible reason for this is that the many proteins in serum aggregated over the 24 
hours at room temperature, which caused a higher fluorescent level, and thus a higher read out. 
However, the 10% serum samples decreased after 24 hours or stayed the same when incubated with 
heparin. This decrease could be from growth factor degradation during the incubation time. In 
contrast, heparin has been seen to protect and stabilize growth factors112. Thus, when incubated with 
10% serum, heparin might protect HGF from degrading and be the reason that the HGF 
concentration remained stable after the 24 hour incubation (Fig. 4.3.4).  
 
Next, the amount of HGF that binds to hydrogels in culture was examined. To do this, 10% cord 
serum in DMEM medium was incubated with the hydrogels for 24 hours at room temperature and 
then the supernatant was removed and the unbound HGF was measured. A low (γ = 0.63) and high 
(γ = 1.0) crosslinked starPEG-heparin hydrogel was used for the study to determine how pore size 
affects HGF binding. Collagen gels were used as a control matrix because they offer a simplistic 
model that exhibits weak binding to proteins159,160. Two different collagen concentrations (0.9 and 3 
mg/ml) were also used. Interestingly, there was negligible difference between the low and high 
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crosslinking density of both types of hydrogels, signifying that in the conditions tested, pore size did 
not affect HGF binding. The results show that as expected, the collagen gels did not bind HGF. In 
contrast, the supernatant from starPEG-heparin hydrogels contained less HGF than 10% cord 
serum at time 0, suggesting that the difference is from HGF binding to the hydrogels (Fig. 4.3.4). 
Based on these results, about 1/3 of HGF in 10% serum binds to the hydrogels.  
 
Previously reported studies found that HGF in the presence of heparin did not alter its binding to 
the cell receptor c-MET, indicating that bound HGF remains bioactive and even may enhance 
mitogenic potency of the growth factor161. Therefore, it is possible that the amount of HGF in 10% 
FBS alone, could be enough to stimulate tubulogenesis in the starPEG-MMP-heparin hydrogels. If 
the system is already saturated with HGF, PTECs would not be sensitive to additional HGF added 
to the system.  
 
Figure 4.3.4. HGF levels in human umbilical cord serum and its binding to hydrogels. HGF concentration was 
measured in 100% serum or 10% serum in DMEM medium. The binding of HGF to hydrogels was also measured by 
incubating 10% serum with two different crosslinked starPEG-heparin hydrogels and two different collagen gel 
concentrations (Mean + s.d.). StarPEG-heparin hydrogel 1 and 2 correspond to the crosslinking degree 0.63, and 1.0, 
respectively. Collagen 1 and 2 correspond to collagen gels made with 0.9 mg/ml and 3 mg/ml. Solid bars indicate HGF 
level after 24 hours of incubation at room temperature (t = 24) and dashed bars indicate the level at time 0 (t = 0).  
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To test this theory, another HK-2 cell experiment was conducted in low serum conditions (5% FBS). 
Two HGF concentrations were examined, 20 and 200 ng/ml. HGF was embedded in hydrogels and 
supplemented to the media in the same way as the previous experiment. As controls, DMEM/F-12 
media with 5% FBS and 10% FBS, the established standard condition, with no HGF was used. 
Samples were kept in culture for 4 weeks. Interestingly, in the lower FBS condition, 20 ng/ml HGF 
was able to increase the tubulogenesis that was seen at week 4 (Fig. 4.3.5A) with significantly less 
smooth spheroids and significantly more tubular structures compared to both 0 ng/ml HGF with 
5% FBS and the standard, 0 ng/ml HGF with 10% FBS. This indicates the importance of HGF in 
promoting tubulogenesis and reveals that it may be more critical than serum. The highest 
concentration of HGF also had significantly less smooth spheroids compared to the controls, 
signifying that more colonies were undergoing tubulogenesis in this condition.  
 
Metabolic activity was also examined at week 4. Although 20 ng/ml HGF had a substantial effect on 
renal tubulogenesis, it only slightly increased metabolic activity of HK-2 cells compared to the 5% 
FBS without HGF, and interestingly had a similar metabolic activity to 10% FBS without HGF (Fig. 
4.3.5B). The highest concentration of HGF (200 ng/ml) promoted a significantly higher metabolic 
activity compared to all other conditions (Fig. 4.3.5B). This agrees with our previous results that 
showed that HGF stimulates the metabolic activity of HK-2 cells (Fig. 4.3.3.B) and demonstrates 
that 10% FBS can be replaced in our hydrogel system with 5% FBS supplemented with 20 ng/ml 
HGF to have a similar metabolic activity and an increased rate of tubulogenesis. However, this study 
should be repeated to confirm these results. 
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Figure 4.3.5. Influence of HGF in low serum culture on tubulogenesis and metabolic activity. HGF was 
embedded in the hydrogels at 2 different concentrations: 20 and 200 ng/ml. Samples were cultured in media with only 
5% FBS. Controls were cultured in standard media with 10% FBS. A) Tubulogenesis quantification at week 4 (Mean ± 
s.d., n=2-3/condition, >100 colonies/condition, ***P<0.001, **P<0.01, *P<0.05, statistics shown on graph compared to 
10% FBS, the same conditions were also significant when compared to 0 ng/ml HGF + 5% FBS (** for 20 ng/ml HGF 
condition and * for 200 ng/ml HGF). B) Metabolic activity of HK-2 cells at week 4 (Mean ± s.d, n=3/condition, 
**P<0.01, *P<0.05). 
 
4.3.2 Impact of MMPs on renal tubulogenesis 
Now that it has been established that tubulogenesis and metabolic activity of HK-2 cells in starPEG-
MMP-heparin hydrogels can be enhanced with growth factors, the next aim was to explore how 
tubulogenesis can be inhibited. Renal tubulogenesis occurs through cell proliferation, migration, 
differentiation, and degradation of ECM46. In addition to growth factors, there are many other 
proteins present in the extracellular renal environment, secreted by proximal tubule cells and other 
cells in proximity. One type of protein commonly found in the epithelial extracellular environment 
are MMPs. MMPs are endopeptidases that are involved in remodeling of the extracellular matrix and 
secreted by a variety of cell types including proximal tubule cells and endothelial cells. As stated 
earlier, proximal tubule epithelial cells secrete MMP-2, 3, 7, 9, 14, and 24146. Several studies have 
revealed that released MMPs play a direct role in tubulogenesis162,163. The aim of this study was to 
investigate if tubulogenesis could be repressed by inhibiting MMP release from proximal tubule cells.  
 
A synthetic small molecule broadband MMP inhibitor (GM6001, Millipore) was used for the study. 
(MW = 388.47). The inhibitor was added to the medium and incubated with the hydrogel samples at 
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a concentration of 20 μM. As a control, PBS was added to the medium in untreated samples. The 
samples were cultured for 3 weeks to determine the effect on renal tubulogenesis.  
 
 
Figure 4.3.6. Influence of MMPs on HK-2 tubulogenesis and metabolic activity. A commercially available 
broadband MMP inhibitor was added to medium for the culture of the tubulogenesis model. A) Tubulogenesis 
quantification. (Mean ± s.d., n=3 condition, >100 colonies/condition) (B) Metabolic activity of HK-2 cells after 3 weeks 
in culture (Mean ± s.d., n = 3). 
 
The quantification of renal tubulogenesis shows that the addition of the MMP inhibitor significantly 
impedes tubulogenesis of HK-2 cells cultured in starPEG-MMP-heparin hydrogels. By week 1, there 
was a considerable difference between the percent of spiny spheroids in the standard conditions 
(control) and the inhibitor treated samples (60% vs. 20% spiny spheroids) (Fig. 4.3.6A). While spiny 
spheroids in the controls started to form tubule structures by week 2, the amount of spiny spheroids 
in the treated samples remained constant compared to week 1. Interestingly, although the 
tubulogenesis was dramatically different between the two conditions, the metabolic activity of HK-2 
cells cultured in both conditions was not significantly different (Fig. 4.3.6B). However, the standard 
deviation was very high between the MMP inhibitor treated samples meaning that the metabolic 
activity results might not be entirely reliable. Indeed, 2 out of 3 gels cultured with the MMP inhibitor 
had unhealthy cells by week 3, the remaining hydrogel had healthy rounded cells. The MMP inhibitor 
effectively inhibited tubulogenesis in the hydrogel model. Therefore, it can be concluded that HK-2 
cells release MMPs and these MMPs are crucial for the formation of tubule structures in starPEG-
MMP-heparin hydrogels.  
 
This conclusion is confirmed by a previously reported human renal tubulogenesis study that found 
that the addition of the endogenous tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-2, to 
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proximal tubule cells in a collagen/Matrigel matrix significantly reduced the number of tubular 
structures57. However, in their study, endothelial cells were co-cultured with the proximal tubule cells 
or cultured with their conditioned media, which they showed to contain MMP-1, 2, and 3. They did 
not test the proximal tubule cell media for the presence of MMPs and the cells also required HGF to 
form tubules. In contrast, our established hydrogel-based model suggests that proximal tubule cells 
may produce their own MMPs which affect the ability of the cells to undergo tubulogenesis, 
probably through a combination of autocrine and paracrine effects. Nevertheless, it should be noted 
that FBS contains many proteins and proteases which could be another source of the MMPs found 
in the hydrogel culture164. To prove that the MMPs in our culture system are produced from the cells, 
further studies should be done with FBS pretreated with a MMP inhibitor.  
 
Taken together, it can be assumed that MMPs in culture help to cleave the hydrogel matrix through 
the MMP sensitive peptide sequence. This then allows the proximal tubule cells to remodel the 
surrounding matrix and give them space to form tubule structures. This theory is supported by the 
work from previously reported studies which demonstrated that MMP-1 and MMP-2 gave MDCK 
cells the ability to penetrate collagen matrices and accelerate or modify tubulogenesis53,165. Our study 
confirmed that MMPs play an important role in orchestrating the complex process of renal 
tubulogenesis. 
 
4.4 Evaluation of organic transport function in generated tubules 
The next objective of the thesis was to examine the function of the HK-2 cell-derived renal tubules. 
One of the main functions of the renal proximal tubule is the transport of potentially toxic organic 
anions such as metabolic wastes, drugs, and pollutants from the blood to the urine. To assess if this 
function was retained in the in vitro tubulogenesis model, generated tubules were incubated with the 
fluorescent organic anion, Lucifer yellow (LY). The lithium salt form of LY (Sigma) was used which 
is a water soluble dye with maximum excitation/emission at 428/536 nm and a molecular weight of 
457.24. 
 
Proximal tubule cells transport LY intracellularly and then secrete the dye into their lumens. This was 
shown by the study by Masereeuw et al. that used confocal microscopy to visualize the uptake of LY 
into killifish proximal tubule cells and the secretion into the tubular lumen39. They were able to 
demonstrate by the addition of a variety of inhibitors, that LY is initially transported by the sodium- 
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Figure 4.4.1. Organic anion transport in tubular structures. Confocal images show tubular structures before and 
after 1 hour incubation with the fluorescent organic anion dye, Lucifer yellow. Scale bar, 100 μm.  
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dependent organic anion transporter and then secreted into the lumen through the sodium-
independent organic anion transporter. To determine if the generated in vitro tubules in this study 
retained the same function, a fluorescent transport assay was developed. 
 
 
Figure 4.4.2. Schematic of transporter washout experiment. Samples were incubated with LY for 1 hour to allow for 
the dye to accumulate in the lumen. The LY-media was then replaced with dye-free medium. The schematic shows the 
resulting situations that could occur: 1) LY could diffuse out of the tubules through a cavity, signifying the structures are 
not polarized or contain a cavity, this would be assumed to be quick (top diagram) or 2) LY remains in the lumen and in 
the proximal tubule cells, demonstrating that LY is actively transported through the cells. 
 
HK-2 cells were cultured in starPEG-MMP-heparin hydrogels as previously described in Section 4.1. 
After 4 weeks in culture, the standard medium was exchanged to DMEM-HAM’s F-12 phenol red 
free medium. Representative tubular structures in the samples were then imaged with confocal 
microscopy. Next, LY was added to the medium and incubated with the hydrogels for 1 hour. At the 
end of the incubation time, samples were reimaged with confocal microscopy. At the beginning of 
the study, when the samples were imaged in phenol red free media, the lumens of the structures were 
empty. They were even void from background staining from the fluorescent DNA stain, Hoechst, 
which can be seen in the hydrogel surrounding the structures (Fig. 4.4.1). This suggests that the 
Hoechst stain solution does not penetrate the lumens, and supports the belief that the proximal 
  Results and Discussion 
 
73 
 
tubule cells form closed polarized epithelial structures. After 1 hour of incubation, Lucifer yellow 
could be seen in the lumens of the generated tubule structures (Fig. 4.4.1). 
 
To verify that LY was transported through the proximal tubule cells and not entering the lumens 
through simple diffusion, a wash out experiment was conducted. After 1 hour incubation with LY, 
medium with LY dye solution was removed, and replaced with dye free media. After 20 hours of 
incubation, it was again imaged by confocal microscopy as shown in the schematic in Fig. 4.4.2. 
After the 20 hour washout, LY dye remained in the lumen of the tubular figure, determined by the 
higher fluorescent intensity compared to the hydrogel (Fig. 4.4.3). LY was also co-localized with 
some of the proximal tubule cells (arrow in Fig. 4.4.3). This demonstrates that the fluorescent 
organic anion dye enters into the lumens of tubular structures through an active transport system and 
not through unspecific diffusion (Fig. 4.4.2). Therefore, the organic anion transporters are functional 
in the in vitro generated tubules. 
 
 
Figure 4.4.3. Washout experiment with organic anion dye to determine function of transporters. Confocal image 
of a renal structure before and after 20 hours washout with LY-free media. Scale bar, 100 μm. 
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4.5 Prospective of starPEG-MMP-heparin hydrogels for primary 
PTEC tubulogenesis studies 
In the previous sections, a hydrogel-based tubulogenesis model was developed, characterized, and 
applied using immortalized proximal tubule cell lines. However, immortalized cell lines often do not 
retain all functions of their primary cell counterparts. Therefore, the next aim of the thesis was to 
validate the established hydrogel model using primary human proximal tubule cells, which are 
presumed to be closer to the in vivo state than immortalized cell lines. Primary proximal tubule 
epithelial cells (PTEC) are difficult to culture due to dedifferentiation, limited supply, expense, and 
low passage use92. To test the hypothesis that heparin-based hydrogels could promote tubulogenesis 
of primary PTECs, single PTECs were embedded in degradable starPEG-MMP-heparin hydrogels 
and non-degradable starPEG-heparin hydrogels. The same conditions were used as for HK-2 cells, 
with 50,000 cells seeded per gel and utilizing hydrogels with a storage modulus of ~500 Pa. The only 
difference between the cultures was the medium, which only had 0.5% FBS and additional 
supplements that are described in detail in the Materials and Methods, Section 3.2.2. Primary PTEC 
were cultured in the hydrogels for 4 or 5 weeks. Phase contrast images were taken weekly to monitor 
primary PTEC morphogenesis.  
 
By day 7 in starPEG-MMP-heparin hydrogels, single PTECs had formed small spheroids that 
expanded throughout the culture. Several spheroids formed a distinct epithelium by day 21 and day 
28 and a few spheroids elongated and formed tubular structures, while a large majority of spheroids 
were small (less than 100 μM) (Figure 4.5.1). To investigate the polarization of the epithelial 
structures, samples were IF stained for the basolateral markers, β-catenin and Na+/K+ ATPase, and 
the apical tight junction protein, ZO-1 (Figure 4.5.2).  
 
 
Figure 4.5.1. Morphogenesis of primary PTEC cultured in starPEG-MMP-heparin hydrogels. Representative 
phase contrast images of primary human proximal tubule cells from single cells to polarized renal structures throughout a 
4 week culture. Scale bar, 500 μM.  
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Primary PTEC derived tubular structures expressed β-catenin, a cell-cell adhesion and gene 
transcription regulator, along the basolateral membrane (Fig. 4.5.2A). β-catenin is a subunit of the 
cadherin complex where it coordinates cell-cell adhesion and also regulates gene transcription by the 
Wnt signaling pathway166. The structures also expressed the basolateral marker Na+/K+ ATPase, also 
known as sodium-potassium pump, which is an transmembrane enzyme fueled by ATP and 
responsible for pumping sodium out of cells and potassium into cells167 (Fig. 4.5.2B). The tight 
junction protein, (ZO-1), was also expressed on the apical membrane, signifying that tight junctions 
are present between the cells. These results verify that primary PTEC derived tubule-like structures 
are fully polarized. The majority of tubule-like structures had completely clear lumens as in the 
representative images in Fig. 4.5.2, suggesting that the structures are mature and functional.  
 
To prove that primary PTEC retain their differentiated phenotypes while cultured in the hydrogels, 
the structures were stained for the proximal tubule marker, lotus tetragonolobus lectin (LTL). Primary 
PTEC in tubule-like structures expressed LTL, demonstrating that primary PTEC preserve their 
differentiated phenotypes after 5 weeks in culture in starPEG-MMP-heparin hydrogels. It should 
also be noted that not all structures in degradable starPEG-MMP-heparin hydrogels formed tubular 
structures by the end of 4 or 5 weeks and some remained as large spheroids (>100 μm). It is 
presumed that with more time these large spheroids would also elongate and form tubular structures. 
Also, by the end of the study there were a large percent of small spheroids (<100 μm). Future 
experiments will need to be done to explore this detail and increase the percent of tubular structures 
that are formed. It is possible that the culture conditions need to be optimized for primary PTEC, as 
they were previously optimized with the immortalized HK-2 cell line which could have different 
proliferation rates leading to differences in tubulogenesis. The difference in serum concentration 
between the two culture systems (0.5% FBS vs. 10% FBS) could be another reason for the lower 
efficiency of tubular formation with primary PTECs. It was previously shown in this thesis in Fig. 
4.3.1 that higher concentrations of FBS led to increased metabolic activity and tubulogenesis of HK-
2 cells, supporting this theory.  
 
Primary PTEC were also cultured in non-degradable starPEG-heparin hydrogels in parallel. In non-
degradable starPEG-heparin hydrogels, the majority of PTECs formed smaller spheroids (<100 μm) 
compared to cells in the degradable starPEG-MMP-heparin hydrogels. Some spheroids in the non-
degradable starPEG-heparin hydrogels were fully or partially polarized which could be seen with β-
  Results and Discussion 
 
76 
 
catenin and ZO-1 IF staining (Fig. 4.5.3). The polarized spheroids often had clear lumens similar to 
the tubule structures seen in the degradable starPEG-MMP-heparin hydrogels. However, some 
spheroids remained smaller and unpolarized, which can be seen in the zoomed out image in Fig. 
4.5.3. These spheroids did not form lumens by week 4. It is possible that the unpolarized spheroids 
needed a longer time in culture to form organized epithelia with clear lumens.  
 
 
Figure 4.5.2. Polarization of primary PTEC-derived tubules in starPEG-MMP-heparin hydrogels. (A) Confocal 
images of a tubular-like structure after 5 weeks of culture.  Zoomed in images show β-catenin and the tight junction 
protein, ZO-1. Scale bar, 100 μm. (B) Confocal images of a tubular-like structure after 5 weeks in culture showing lotus 
tetragonolobus lectin (LTL) and Na+/K+ ATPase. Scale bar, 100 μm. 
 
With the established degradable heparin-based hydrogel model, human primary PTECs were 
stimulated to undergo tubulogenesis under low serum (0.5% FBS) conditions. Previous 
tubulogenesis studies using primary human PTECs required the addition of hepatocyte growth factor 
(HGF) or high serum concentrations to promote tubulogenesis57,94,95. Alternatively, the only growth 
factor added to cultures of PTECs in starPEG-MMP-heparin hydrogels was 20 ng/ml EGF and 
traces of a range of growth factors found in 0.5% FBS. Miya et al. found that even with the addition 
of 1,000 ng/ml of HGF, only about 60% of colonies formed tubular structures after 5 days in a 
mixture of Matrigel/collagen I57. After 7 days in culture, the HGF-induced tubular structures were 
small with a diameter less than 10 μm, much lower than the human physiological size (41.5 ± 6.2 
μm)
135
. In addition, TEM micrographs showed that the cells were shorter than PTECs in vivo (< 2 
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μm in Matrigel/collagen vs. ~8 μm in vivo)57,135. However, it is possible that, if the culture was kept 
longer, the structures would have grown larger.  
 
 
 
Figure 4.5.3. Primary PTECs form spheroids in non-degradable starPEG-heparin hydrogels, similar to HK-2 
cells. Confocal images of primary human PTECs after 4 weeks in culture. Scale bars, 100 μm. 
 
Importantly, all previous 3D primary PTEC tubulogenesis models were cultured in Matrigel, 
collagen, or a mixture of Matrigel/collagen, which do not allow for tuning of the matrix to study 
tubulogenesis or for disease modeling57,94,95. They also have batch to batch variation, leading to issues 
in reproducibility. To the best of our knowledge, this is the first model where human primary PTECs 
can be monitored from single cells to physiologically sized tubule structures in a fully controlled and 
tunable 3D matrix.  
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4.6 Potential of starPEG-MMP-heparin hydrogels as an in vitro 
nephrotoxicity model  
The kidneys, in particular the proximal tubule cells, are massively affected by drug toxicity168,169. 
Current nephrotoxicity assays rely on 2D cell culture and animal models65. However, only a limited 
number of animal experiments accurately predict the human  response to drugs8,9 and cells grown on 
conventional 2D tissue culture substrates lack the cell-cell and cell-matrix interactions that are crucial 
in maintaining cell phenotype and function10. As a consequence, adverse drug reactions are often not 
found until human clinical trials. As an alternative to 2D systems, animal models provide a 
physiological 3D environment, but often cannot predict the response of the human kidney due to 
interspecies differences. Therefore, there is a critical need for more reliable and representative human 
nephrotoxicity assays which accurately recapitulate the human 3D structure and function of proximal 
tubules in a robust, tunable matrix that can be easily analyzed in throughput screenings for toxicity. 
 
For these reasons, the established hydrogel-based tubulogenesis model was evaluated for its efficacy 
as a nephrotoxicity assay. Cisplatin, a chemotherapeutic drug known to be highly nephrotoxic, was 
chosen for the studies. Cisplatin has been shown to be actively transported into proximal tubule 
cells, where it leads to cell injury and apoptosis74,75. HK-2 cells were embedded in starPEG-MMP-
heparin hydrogels and cultured under standard conditions for 4 weeks to allow the cells to form 
branched structures as seen in Fig. 4.2.2C. The medium was then removed and replaced with serum-
free DMEM/F-12 medium containing 0 to 100 μM cisplatin and incubated for 48 hours.  
 
 
Figure 4.6.1. Morphology of tubular structures before and after cisplatin treatment. Samples were incubated with a 
range of cisplatin from 0-100 μM for 48 hour. Scale bar, 100 µm.  
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The architecture of the tubular structures was markedly altered after incubation with the nephrotoxic 
cisplatin. After incubation with 50 µM of cisplatin, the architecture of some tubular structures started 
to deteriorate which can be seen in Fig. 4.6.1. To investigate this further, and also determine the 
amount of apoptotic cells in the culture, samples were stained for F-actin and cleaved caspase-3, a 
marker for apoptosis. The control samples show clear actin staining around the borders of the renal 
structures, as expected (Fig. 4.6.2). However, with the addition of cisplatin the presence of actin 
became less pronounced and with the highest concentration of 100 μM cisplatin, only small sections 
of actin were remaining (Fig. 4.6.2). Importantly, there was a dose-dependent response in apoptotic 
cells, which agrees with established mouse models of nephrotoxicity that reported increased 
apoptosis in proximal tubule cells75 (Fig. 4.6.2). 
 
It has previously been reported that at low concentrations cisplatin induces apoptosis in primary 
mouse proximal tubular cells whereas high concentrations lead to necrosis80. For this reason, the 
amount of necrosis in the cultures was also examined by measuring the lactate dehydrogenase (LDH) 
release in the supernatant. LDH is an enzyme released by cells following injury to the plasma 
membrane and can be used to quantify necrotic cells133. After a 48 hour incubation with cisplatin, 
LDH was measured in the supernatant. The metabolic activity of the cells was also analyzed. 
 
 
Figure 4.6.2. Dose-dependent apoptosis response to nephrotoxins. Representative confocal images of apoptotic 
marker, cleaved caspase-3, after application of a cisplatin gradient for 48 hours. Scale bar, 100 μM. 
 
A decrease in metabolic activity and an increase in LDH release was observed with increasing 
concentrations of cisplatin (Fig. 4.6.3.). These results show that cisplatin has a dose-dependent effect 
on the tubular structures. From the metabolic activity results the EC50 value for the hydrogel-based 
tubulogenesis model is estimated to be ~27 μM. In contrast, conventional 2D cultures with kidney 
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cell lines often require dosages that are orders of magnitude higher. For example, Astashkina et al. 
found that the kidney cell lines HEK and LLC-PK1 have a cisplatin EC50 value of 2.7 mM and 2.0 
mM, respectively170. In contrast, in our hydrogel-based model, HK-2 derived tubular structures have 
an EC50 that is close to the value found by Li et al. for primary human proximal tubule cells (39.57 
μM, determined by cell viability)171. Therefore, the established tubule model is a better representation 
of human primary proximal tubule cells than other renal cell lines.  
 
Additionally, the established hydrogel-based tubule model was compared to animal nephrotoxicity 
models. Cisplatin dosages were recalculated to our model using the average weight per experimental 
well which was found by Bray et al. to be 35.38 mg per gel and 1 g of solution, making a total of 
1.03538 g101. Established mouse models of nephrotoxicity commonly use a dose of 20 mg/kg 
cisplatin body weight, which results in an increased apoptosis in proximal tubule cells75,172. In 
comparison, our in vitro tubulogenesis model after incubation with 20 mg/kg (69 μM cisplatin 
calculated to our system), shows an increase in apoptosis that can be seen in the expression of 
cleaved caspase-3 IF, as well as a decrease of metabolic activity and increase in cytotoxicity compared 
to controls (Fig. 4.6.2 and Fig. 4.6.3). Therefore, our in vitro hydrogel-based model could potentially 
be used in the future as an alternative to animal nephrotoxicity models. 
 
 
Figure 4.6.3. Cisplatin-induced dose response on metabolic activity and LDH release. Metabolic activity and 
cytotoxicity (LDH release) of tubular structures after 48h treatment with cisplatin (Mean of pooled experiments ± s.e.m., 
n = 2-4, experiments performed in triplicate). 
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Metabolic activity, apoptosis, and necrosis are common markers for drug-induced injury, however, 
recent interest has gone into the exploration of renal biomarkers that can detect the early onset of 
injury and disease64,173. To test the sensitivity of the generated tubular structures, the expression of 
the in vivo proximal tubule specific renal injury biomarker, KIM-1, was then investigated after 
incubation with cisplatin. Immunofluorescence staining revealed that KIM-1 was upregulated in 
tubular structures after treatment with 50 μM cisplatin (Fig. 4.6.4). KIM-1 was also expressed at 
lower levels in 25 μM treated samples, signifying a dose dependency of its expression. It should also 
be noted that some renal structures treated with 25 μM cisplatin had KIM-1 levels similar to the 
untreated control (Fig. 4.6.4), suggesting that the critical concentration that induces KIM-1 is 
between 25 and 50 µM. 
 
To validate these results, the experiment was repeated with primary human PTECs using 25 and 50 
μM of cisplatin. The same conditions were used as for the HK-2 cell nephrotoxicity experiments, 
with the exception that PTEC media was used instead of HK-2 media. The primary PTEC derived 
tubular structures expressed KIM-1 after incubation with 50 μM cisplatin (Fig. 4.6.5). When the 
PTEC derived tubular structures were incubated with 25 μM of cisplatin they showed a variable 
expression of KIM-1. Thus, the primary PTC derived structures confirm the nephrotoxicity results 
from our previous HK-2 cell study and show potential as a model for personalized nephrotoxicity. 
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Figure 4.6.4. Expression of the biomarker KIM-1 after cisplatin treatment. Confocal images of kidney injury 
molecule-1, KIM-1, expression in HK-2 cell derived tubular structures after 48 hour cisplatin treatment. Scale bar, 75 µm. 
 
The established model was then compared to doses used in the human clinic. The highest dose used 
on humans is 100 mg/m2  174. This concentration was recalculated to our system using the Km factor 
method proposed by Reagan-Shaw et al175. Specifically, the dose was divided by the human Km factor 
to get a concentration in mg/kg. Then the dose of drug needed per well was found using the average 
weight in each well, 1.03538 g as stated earlier. The value was then converted to moles using the 
molecular weight of cisplatin and finally, the molarity was found in 1 ml of media. By applying this 
method, the highest human dose of cisplatin, 100 mg/m2, would be ≈ 9 µM. Although this cisplatin 
concentration is perhaps too low to show an increase in apoptosis in our model, it does show a 
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decrease in metabolic activity and an increase in LDH release (Fig. 4.6.3). Hence, our hydrogel-based 
in vitro tubulogenesis model is sensitive to nephrotoxin concentrations that affect the human kidney. 
Altogether, this established model could make a large impact on the field of nephrotoxicity by 
providing more reliable preclinical assays and limiting the need for animal models.  
 
 
Figure 4.6.5. Cisplatin-induced expression of KIM-1 in primary human PTEC-derived tubular structures. 
Primary human PTECs were cultured in starPEG-MMP-heparin hydrogels for 4 weeks and then subsequently incubated 
with cisplatin for 48 hours. Confocal micrographs show IF staining of the biomarker, KIM-1, after treatment with 
cisplatin. Scale bar, 50 μm. 
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Chapter 5 
General Discussion 
5.1 Summary and conclusions 
Due to the rising prevalence of chronic kidney disease and end stage renal disease, scientists have 
begun to research alternative renal regenerative therapies. In order to discover new therapies, an 
accurate model of the human kidney is required. The ideal model would contain the complex 
functions of the human kidney in a tunable and easily observable system. Currently, the majority of 
preclinical trails are performed with animal models, which often contain interspecies differences. An 
in vitro renal model could circumvent these issues by providing a system where human cells can be 
used and the response to treatment could be visualized in real time, rather than sacrificing animals at 
predetermined time points. In this way, the strength and duration of a treatment could be better 
evaluated. A 3D in vitro model would also be a better representation of the physiological environment 
compared to 2D cell culture models, while still allowing simple cell modification such as gene editing. 
Although there have been many advances in this field in the past few years, a clinically relevant 3D 
model that retains the functions and anatomy of the mature human kidney in a tunable system has 
not yet been established20,176. 
 
The aim of this thesis was to create an in vitro 3D renal tubulogenesis model using the tunable 
biohybrid starPEG-heparin hydrogel platform. Hydrogels with a range of mechanical properties and 
compositions were evaluated to determine the optimal conditions to promote renal tubulogenesis. 
The results revealed that soft hydrogels composed of heparin and MMP cleavable peptides 
(starPEG-MMP-heparin hydrogels) were the only condition to produce tubule structures. The 
tubules displayed polarization markers, extracellular matrix components, and organic anion transport 
function of the human renal tubule.  
 
Remarkably, in starPEG-heparin hydrogels (no MMP cleavable peptide), PTECs formed polarized 
spheroids, whereas in degradable starPEG-MMP-starPEG hydrogels (no heparin), the cells formed 
unorganized colonies. From these results, two main conclusions were determined: 1) heparin plays a 
role in the organization of PTECs in the presented 3D model and 2) the combination of heparin and 
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a cleavable matrix are crucial for the formation of tubular structures in the hydrogel culture. 
Interestingly, heparan sulfate, which has similar characteristics to heparin, is the main GAG found in 
human kidney and has been reported to facilitate lumen formation in organotypic cultures of  
embryonic lung epithelial cells177,178. To the best of our knowledge, this is the first time that heparin 
has been incorporated into a hydrogel for use as a proximal tubule model. These results also indicate 
that immortalized proximal tubule cell lines (HK-2 cells) have the ability to form physiologically 
relevant proximal tubule structures, possibly limiting the dependence on less assessable primary 
proximal tubule cells.  
 
To probe the ability of the hydrogel-based system as a model for renal tubulogenesis, experiments 
were performed with pro- or anti-tubulogenic soluble factors supplemented in the culture. A serum 
substitution study to determine the importance of growth factors in serum was also performed. 
Results from these studies showed that growth factors are necessary for tubulogenesis and the 
generation of tubule structures can be enhanced by increasing concentrations of single factors. In 
contrast, when a MMP inhibitor was added to the cultures, tubulogenesis was inhibited. Thus, the 
findings revealed that tubulogenesis could be modulated by adding soluble cues to the culture 
medium and to the hydrogels themself. In overall, these results suggest that the hydrogel-based 
model can be used for studying renal tubulogenesis, potentially for regenerative medicine 
applications. 
 
As a proof of principle, the hydrogel-based model was then applied to primary PTECs. Single 
primary PTECs extracted from healthy human kidneys were embedded in the hydrogels. Findings 
showed that human primary PTEC formed polarized epithelial structures with clear lumens in 
starPEG-MMP-heparin hydrogels. In addition, the renal structures also possessed the proximal 
tubule specific lectin, lotus tetragonolobus (LTL), confirming that the PTECs retain their differentiated 
phenotype and generate proximal tubule-like structures. Remarkably, these polarized structures 
formed in culture conditions of only 0.5% FBS.  
 
As far as we are aware, this is the first time that human primary PTECs have been stimulated to 
undergo tubulogenesis ex vivo without the addition of HGF or high serum concentrations in a 
synthetic matrix. Results from the primary PTEC study indicate that renal tubule cells have an 
inherent ability to reconstruct tubule-like structures and therefore, could have an important use in 
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renal regenerative medicine. The source of in vivo tubule regeneration is a controversial topic with 
different modes of regeneration believed to be active after injury; they include dedifferentiation of 
PTECs, compensatory hyperplasia, and a resident pool of progenitors/stem cells among 
PTECs179,180. The established renal tubulogenesis model could be used to further study these 
mechanisms. 
 
The next aim of the study was to evaluate the efficacy of the hydrogel-based renal model as a 
nephrotoxicity assay. The potent chemotherapy drug cisplatin, a known nephrotoxin, was incubated 
with the renal tubule model. The tubular structures showed a dose-dependent drug response and the 
injured tubular structures expressed the early in vivo proximal tubule injury biomarker, kidney injury 
molecule-1 (KIM-1). Remarkably, the generated tubules were responsive to drug concentrations on 
the same range as concentrations used in the human clinic. Therefore, the developed renal 
tubulogenesis model recapitulates a similar nephrotoxic response of the human kidney.  
 
Altogether, in this thesis, we successfully developed and characterized a renal tubulogenesis model 
based on starPEG-MMP-heparin hydrogels. To the best of our knowledge, this is the first system 
where human renal tubulogenesis can be monitored ex vivo from single cells to physiologically sized 
tubule structures in a 3D tunable matrix. This model can be used to modulate tubulogenesis by 
adjusting hydrogel mechanics, growth factor signaling, and the presence of insoluble cues (such as 
adhesion peptides), potentially providing applications for regenerative medicine or disease modeling. 
Additionally, the model could be used for drug toxicity tests as an alternative to animal models. The 
ability of immortalized PTEC lines to create human-like structures opens options for high 
throughput assays, whereas the results with primary PTEC demonstrate that the model could 
potentially be used for personalized medicine. In conclusion, a versatile 3D renal tubulogenesis 
model was successfully established using tunable, degradable starPEG-MMP-heparin hydrogels and 
shows promise in a range of applications.  
 
5.2 Future perspectives 
The established hydrogel-based renal tubulogenesis model is a versatile tool for studying renal 
tubulogenesis. However, it does contain some limitations and ways where it can be approved upon. 
This section will briefly comment on these limitations and then how the model can be further 
utilized for future applications. 
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An important finding of the thesis is the discovery of heparin’s contribution to proximal tubule cell 
polarization in 3D cultures. As it was previously mentioned in Section 4.2.2, there are various reasons 
that could contribute to this occurrence such as the stabilization of soluble factors or the anchoring 
of ECM. To better understand the role of heparin, it would be interesting to embed human proximal 
tubule cells in other GAG-based hydrogels. For example, hydrogels could potentially be formed with 
chondroitin sulfate, a glycosaminoglycan consisting of repeating disaccharide units containing N-
Acetylgalactosamines rather than the N-acetylglucosamines in heparin181. Chondroitin sulfate could 
be used to form starPEG-chondroitin sulfate hydrogels that are similar to starPEG-heparin 
hydrogels. In this way, specific characteristics of heparin such as charge, size, and structure could be 
investigated to determine their influence on renal tubulogenesis.  
 
Another GAG-based hydrogel that could give important insights into the mechanism behind heparin 
is hyaluronan, a nonsulfated glycosaminoglycan. Embedding proximal tubule cells in engineered 
hydrogels constructed of starPEG and hyaluronan would show how the lack of sulfate groups affects 
renal tubulogenesis. If proximal tubule cells do not form tubular structures in starPEG-hyaluronan 
hydrogels, it would highly suggest that the sulfate groups, and hence, the charge of the heparin is 
crucial in promoting renal tubulogenesis. This theory could be probed even further by embedding 
proximal tubule cells in starPEG-MMP-heparin hydrogels with various degrees of desulfation. This 
could be valuable knowledge for kidney development and renal regenerative medicine studies, as well 
as improve upon the established renal tubulogenesis model. 
 
Another finding from the thesis was the influence of FBS and growth factors, specifically HGF on 
renal tubulogenesis. It was shown that immortalized proximal tubule cells (HK-2) do not form 
tubular structures when incubated with the commercially available serum substitute, panexin NTA 
(Fig. 4.3.2), instead of the standard FBS. It would be interesting to see if this effect could be 
reversed, particularly if HGF and/or additional growth factors could be used in combination with 
the serum substitute to promote renal tubulogenesis that occurs with 10% FBS. If this could be 
achieved, it would present a simplistic model where individual soluble factors can be examined 
without the presence of the complex FBS.  
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The established renal tubulogenesis model could also be used to further investigate the individual 
MMPs that influence renal tubulogenesis. As it was shown with the addition of a broadband MMP 
inhibitor, along with other published studies, MMPs are needed for renal tubulogenesis. However, in 
the established starPEG-heparin hydrogel renal tubulogenesis model, the distinct MMPs necessary 
are unclear. A wide range of MMP inhibitors have been created that can impede the function of two 
MMPs or even a single MMP182. By adding these inhibitors to the established renal tubulogenesis 
model, the role of specific MMPs can be determined. Understanding the MMPs that are involved in 
proximal tubulogenesis is important for the creation of new regenerative therapies, where MMPs 
could potentially be used as a treatment. 
 
It was shown that the organic anion dye, LY, could be transported from the basal side of the renal 
structures (in cell culture medium) to the apical side of the renal structures (lumen). Although this 
data suggests that LY is being transported into the cells through organic anion transporters, it 
presents an indirect proof. In order to directly prove that the organic anion transporters are active in 
the movement of LY, the commercially available organic anion transporter (OAT) inhibitor, 
probenecid could be introduced to the cultures. If the addition of probenecid, decreased the amount 
of LY that was displayed in the lumen of renal tubule structures, it would prove that the OATs are 
actively transporting LY through the cells.  
 
The use of other fluorescently labeled proteins with various molecular weights could be used to 
further test the tissue-specific barrier functions of the renal tubule structures and verify the organic 
transporters. For example, the polysaccharide dextran is commercially available with molecular 
weights ranging from 3-70 kDa and can be conjugated to fluorescein isothiocyanate (FITC) or 
rhodamine for visualization84,183,184. Freedman et al. found that rhodamine-dextran (MW 10 kDa) 
localized to tubular lumens of the majority of renal organoids and Takasato et al. saw proximal 
tubule regions of organoids endocytosed dextran-Alexa48883,84. This effect could be markedly 
reduced by the addition of latrunculin B which inhibits actin polymerization and endocytosis84. This 
approach could easily be repeated in our model using the transporter assay that was constructed to 
test LY transport. In addition, to verify that the proximal tubule cells form tight junctions in the 
tubular structures, inulin-FITC, a low molecular weight (4.5 kDa) compound that is neither 
reabsorbed nor secreted by in vivo renal tubules, could also be added to the cultures121,183. If no inulin-
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FITC accumulated in the lumen of the generated renal tubules, it would verify that the proximal 
tubule cells form fully enclosed tubular structures that consist of a tight monolayer of cells.  
 
Another way the tissue specific functions of the generated renal tubule structures could be examined 
is by their response to other non-renal toxins. For example the renal tubulogenesis model could be 
incubated with the liver toxin, D-galactosamine, which causes apoptosis and necrosis in hepatocytes 
in vivo 185,186. If the treated proximal tubule cells show a similar response to the untreated control, it 
would prove that the proximal tubule cells retain tissue specific function. 
 
The hydrogel model was applied to human primary proximal tubule cells where they formed 
polarized renal structures. Some of these structures elongated and formed tubule like structures. 
However, further studies should aim to increase the amount of tubule structures that are formed 
from primary proximal tubule cells. This could be done by changing cell concentrations and hydrogel 
stiffness. Also, the addition of growth factors such as HGF, EGF, and FGF-2 could be implemented 
in the cultures to increase the rate of tubulogenesis. 
 
In this thesis, it was shown that the established hydrogel-based renal tubulogenesis model could be 
used as a nephrotoxicity assay through the results with cisplatin incubation. To verify this further, 
other nephrotoxins could be applied to the system using the same nephrotoxicity parameters 
established in this thesis. In addition to nephrotoxicity applications, the hydrogel-based model can 
also be used for disease modeling. For example, the mechanical properties of the hydrogel can be 
adjusted to simulate a fibrotic state that is representative of end stage renal disease.  
 
It would also be interesting to explore the cisplatin-induced renal tubule injury model further to 
determine if the injury could be recovered. This could be done by incubating the generated tubules 
with cisplatin for a specific time point, then replacing the medium with normal cisplatin-free medium 
and keeping the samples in culture. The injury of the proximal tubules could be monitored over time 
to determine if they can recover similar to in vivo. If this would be possible, the model could be used 
as an in vitro acute renal injury model.  
 
One of the main limitations of the model is that is a simplistic view of the nephron and does not 
contain the full complexity of the kidney. In the in vivo environment, proximal tubules are adjacent to 
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peritubular capillaries with which they are constantly exchanging molecules through reabsorption and 
secretion (Fig. 2.1.1). To replicate this in the established hydrogel system, renal proximal tubule cells 
could be co-cultured with endothelial cells in starPEG-MMP-heparin hydrogels. Previous studies 
have already shown that endothelial cells can form blood vessels in the in situ starPEG-MMP-heparin 
hydrogels100. Therefore, it would be interesting to see if blood vessels could form parallel to the 
formation of the renal tubules, if the rate of tubulogenesis could be increased, and if the structures 
would arrange together.  
 
This proposed co-culture model could be valuable to have a more morphologically correct model of 
the proximal tubule environment. However, there would still remain a lack of blood supply, limiting 
the exchange of molecules between the two structures. To address this concern, the hydrogel-based 
co-culture system could be grafted to a chicken chorioallantoic membrane (CAM)187,188. This would 
potentially provide a source of blood to the system. An alternative way to assess the starPEG-
heparin hydrogel-based renal tubulogenesis model in vivo is implantation of the hydrogel under the 
kidney capsule189. This method could provide vascularization to the system through the kidneys own 
blood vessels. Finally, the physiological function of the proximal tubules could be evaluated by 
injecting fluorescently conjugated proteins into the blood system of the animal host to see if they 
accumulate in the generated implanted tubule structures.  
 
Additionally, if the 3D renal model could be used in a high-throughput design it would broaden its 
applicability as a preclinical model for drug screening or regenerative medicine studies. This could 
potentially be done using a 3D printer to print the hydrogels more efficiently or optimizing the 
model for use in 96 well plates to increase the number of factors that can be examined in one 
experiment. Future studies should apply these methods to the starPEG-MMP-heparin hydrogel renal 
tubulogenesis model to demonstrate the efficacy of the model for high throughput screening. In 
conclusion, we have established a hydrogel-based renal tubulogenesis model that can be used for 
several different applications. 
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Appendix 
Chapter 6: Supplementary materials and methods 
 
6.1 Materials for peptide synthesis 
All solvents and reagents for peptide synthesis were purchased from IRIS Biotech GmbH 
(Marktredwitz, Germany). Tris (2-carboxyethyl) phosphine (TCEP) was purchased from Sigma-
Aldrich Company (St. Louis, USA). Four-armed maleimide terminated polyethylene glycol (starPEG-
mal) (MW = 10.0x103; PDI = 1.08) and four-armed thiol terminated polyethylene glycol (starPEG) 
was purchased from JenKem Technology USA Inc. (Allen, USA). All the reagents were used without 
preliminary purification.  
 
6.2 Methods for peptide and conjugate synthesis 
All peptide synthesis and purification of the MMP cleavable peptide and the starPEG-MMP 
conjugate was performed by Dr. Mikhail Tsurkan. Milauscha Grimmer performed all synthesis and 
purification of heparin-maleimide conjugates. 
 
6.2.1 Peptide syntheses and purification 
The MMP-cleavable Ac-GGPQGIWGQGGCG-NH2 (MMP) peptide was synthesized by solid-
phase methods using an Activo P14 (Activotec, Cambridge UK) peptide synthesizer and standard 
Fmoc-chemistry. Specifically, a 4 mmol scale protocol with a C-terminal capping protection strategy 
by amide was used. Amino acid activation was achieved by O-(benzotriazol-1-yl)-N, N, N', N'-
tetramethyluronium tetrafluoroborate (TBTU), and 1-hydroxybenzotriazole (HOBt) in DMF with 
diisopropylethylamine (DIPEA) as a base. Deprotection of amino acid side chains and cleavage from 
the resin was performed by reaction with a mixture of trifluoroacetic acid (TFA) (87, 5% v/v), 
phenol (5% v/v), tri-isopropyl silane (TIPS) (2.5% v/v), and water (5% v/v) for 2.5 hours at room 
temperature. The crude peptides were then precipitated in anhydrous diethyl ether, collected by 
vacuum filtration, and dried under vacuum. Final purification was achieved by preparative reversed-
phase high performance liquid chromatography (HPLC). All peptide purification was performed by 
HPLC on a preparative reversed-phase Phenomenex Lune Prep C-18 column (10μM particle size, 
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250×30 mm; Phenomenex, Torrance, USA). A linear gradient of water/acetonitrile containing 0.1 % 
(v/v) trifluroacetic acid was used as the mobile phase. The HPLC separation runs were performed 
over 30 min using the flow rate of 10 ml/min and the monitoring wavelengths were set to a 
wavelength range of 210-278 nm. A two-pump system (1200 Series; Agilent Technologies, Santa 
Clara, USA) equipped with an UV/Vis diode array detector/spectrophotometer and a 1 cm path 
length cell was used. The collected peptide was lyophilized, and its purity was verified by analytical 
HPLC and electrospray ionization mass spectrometry (Agilent Technologies 6230 TOF LC/MS 
spectrometer, Applied Biosystems, USA).  
 
6.2.2 Synthesis and purification of cysteine-terminated PEG-(MMP)4  
StarPEG-MMP conjugate was synthesized as previously described29. In brief, 100 mg of four arm 
star-shaped, maleimide-terminated PEG-(Maleimide)4 (Mw=10000) was dissolved in 1 ml of water 
and mixed with 61 mg of MMP peptide (5% excess) which was dissolved in 0.5 ml of ddH2O. Next, 
0.5 ml of Phosphate buffer pH 7.4 was added. The pH of the reaction mixture was adjusted to pH 
7.5-8 by 1M NaOH. The reaction was run for 5 hours under N2 atmosphere, and the completion of 
the reaction was followed by HPLC. In order to remove StBu protection group, a five times molar 
excess (to the peptide) TCEP solution (pH 7-8) was added to the reaction mixture and was stirred at 
room temperature for several hour. Next, the reaction mixture was evaporated till dry, dissolved in 
water and purified by preparative HPLC. The product was collected from the HPLC, mixed with 0.1 
ml of 1M HCl and freeze-dried for greater than 24 hours. The formed white powder was then stored 
at -20°C.  
 
6.2.3 Synthesis and purification of heparin-maleimide conjugates 
All the heparin maleimide conjugates were synthesized as previously described29,32. Briefly, Threefold 
molar excess of EDC and 1.5 fold molar excess of sNHS (referring to the maleimide amine) were 
added to a solution of 0.5 g of heparin dissolved in 3 ml of ultrapure H2O. The reaction mixtures 
were kept at 4 °C for 20 min. Next, N-(2-aminoethyl) maleimide trifluoroacetate salt dissolved in 
ddH2O (at 5 °C) was added to the reaction mixtures and stirred overnight at room temperature. The 
amount of maleimide amine (5% excess to the theoretical amount) was 57.3 mg for HM6 and for 
76.5 mg HM8 conjugate which correspond to six and eight maleimide molecules per heparin 
correspondently. The conjugates were purified by dialysis (membrane with 8kDa molecular weight 
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cut-off) against 1L of 1M sodium chloride three times followed by dialysis against 1L of water five 
times in order to remove any unreacted maleimide amine. The products were then freeze-dried for at 
least 24 hours and stored at -20 °C. The purity and reactively of the formed conjugates were 
controlled by HPSEC (1100 Series; Agilent Technologies, Santa Clara, USA). For these studies, 
heparin was functionalized with maleimide groups at a molar ratio of 1:8. 
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Appendix 
Chapter 7: Supplementary results 
 
 
Figure 7.1. Comparison of the ultrastructure between in vivo and in vitro renal structures. (A) TEM micrograph 
of a descending thin limb in a rat kidney. Arrows represent tight junctions. Scale bar, ~6 μm using X3750 parameters. 
Adapted from Pannabecker190. (B) TEM micrograph of HK-2 cell-derived structure cultured in degradable starPEG-
MMP-heparin hydrogels. HK-2 cells were cultured for 4 weeks and then fixed and processed for TEM imaging. Scale 
bar, 10 μm. The reader is referred to Junqueira’s Basic Histology Text & Atlas for a TEM micrograph of a thin limb of 
the loop of Henle in a human kidney22.  
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Nomenclature 
2D  Two-dimensional 
3D  Three-dimensional 
AKI  acute kidney injury 
BSA  bovine serum albumin 
BUN  blood urea nitrogen 
CAM  chicken chorioallantoic membrane 
ciPTEC conditionally immortalized proximal tubule epithelial cells 
cisplatin Cis-Diamineplatinum (II) (chemotherapeutic drug) 
DMEM Dulbecco’s modified essential media 
HK-2  immortalized human proximal tubular epithelial cells 
ECM Extracellular matrix 
EDC 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EGF Epidermal growth factor 
FCS/FBS Fetal calf serum/fetal bovine serum 
FITC fluorescein-isothiocyanate 
GAGs glycosaminoglycans 
GBM glomerular basement membrane 
HCS Human umbilical cord serum 
HEK  human embryonic kidney cells 
HGF Hepatocyte growth factor 
IHC Immunohistochemistry 
IF Immunofluorescence 
KIM-1 Kidney injury molecule-1 
kDa kilodalton 
kPa kilopascal 
LDH Lactate dehydrogenase 
LLC-PK1 porcine kidney epithelial cells 
LTL lotus tetragonolobus lectin 
LY Lucifer yellow (organic anion dye) 
MDCK Madin-Darby canine kidney epithelial cells 
MM metanephric mesenchyme 
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MMP Matrix metalloproteinase 
MRP multidrug resistance proteins 
MW molecular weight 
Pa Pascals 
PEG poly (ethylene glycol 
PBS phosphate-buffered saline 
P/S penicillin/streptomycin 
PEG poly (ethylene glycol) 
PTEC proximal tubule epithelial cells 
OAT organic anion transporter 
OCT organic cation transporter 
RGD Arg-Gly-Asp 
SCr serum creatinine 
s.d. standard deviation 
s.e.m. standard error of the mean 
sNHS N-hydroxysulfo-succinimide 
starPEG four-armed thiol functionalized PEG 
starPEG-mal four-armed maleimide terminated PEG 
starPEG-MMP four-armed PEG end functionalized with MMP cleavable peptide  
TEM Transmission electron microscopy 
TIMP tissue inhibitors of metalloproteinases 
UB ureteric bud 
ZO-1 zonula occluden-1 
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